false Q2 --03-31 2026 0001420924 0001420924 2025-04-01 2025-09-30 0001420924 2025-11-19 0001420924 2025-09-30 0001420924 2025-03-31 0001420924 us-gaap:NonrelatedPartyMember 2025-09-30 0001420924 us-gaap:NonrelatedPartyMember 2025-03-31 0001420924 us-gaap:RelatedPartyMember 2025-09-30 0001420924 us-gaap:RelatedPartyMember 2025-03-31 0001420924 2025-07-01 2025-09-30 0001420924 2024-07-01 2024-09-30 0001420924 2024-04-01 2024-09-30 0001420924 us-gaap:CommonStockMember 2024-03-31 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001420924 us-gaap:RetainedEarningsMember 2024-03-31 0001420924 2024-03-31 0001420924 us-gaap:CommonStockMember 2024-06-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001420924 us-gaap:RetainedEarningsMember 2024-06-30 0001420924 2024-06-30 0001420924 us-gaap:CommonStockMember 2025-03-31 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001420924 us-gaap:RetainedEarningsMember 2025-03-31 0001420924 us-gaap:CommonStockMember 2025-06-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001420924 us-gaap:RetainedEarningsMember 2025-06-30 0001420924 2025-06-30 0001420924 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001420924 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001420924 2024-04-01 2024-06-30 0001420924 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001420924 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001420924 us-gaap:CommonStockMember 2024-04-01 2024-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-09-30 0001420924 us-gaap:RetainedEarningsMember 2024-04-01 2024-09-30 0001420924 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001420924 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001420924 2025-04-01 2025-06-30 0001420924 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001420924 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001420924 us-gaap:CommonStockMember 2025-04-01 2025-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-09-30 0001420924 us-gaap:RetainedEarningsMember 2025-04-01 2025-09-30 0001420924 us-gaap:CommonStockMember 2024-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001420924 us-gaap:RetainedEarningsMember 2024-09-30 0001420924 2024-09-30 0001420924 us-gaap:CommonStockMember 2025-09-30 0001420924 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001420924 us-gaap:RetainedEarningsMember 2025-09-30 0001420924 2025-05-28 2025-05-28 0001420924 2024-04-01 2025-03-31 0001420924 ADTI:BallengeeGroupMember ADTI:PurchaseAgreementMember 2025-07-14 0001420924 ADTI:BallengeeGroupMember ADTI:PurchaseAgreementMember 2025-07-14 2025-07-14 0001420924 ADTI:BallengeeGroupMember ADTI:PurchaseAgreementMember srt:MaximumMember 2025-07-14 2025-07-14 0001420924 ADTI:BallengeeGroupMember 2025-07-14 2025-07-14 0001420924 ADTI:BallengeeGroupMember 2025-07-14 0001420924 ADTI:BallengeeGroupMember srt:MinimumMember 2025-07-14 2025-07-14 0001420924 ADTI:BallengeeGroupMember ADTI:PromissoryNoteMember 2025-07-14 0001420924 ADTI:MarketingIncomeMember 2025-07-01 2025-09-30 0001420924 ADTI:ClientExpensesMember 2025-07-01 2025-09-30 0001420924 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ADTI:FiveAgentsMember 2024-12-31 2024-12-31 0001420924 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember ADTI:TenAgentsMember 2023-12-31 2023-12-31 0001420924 srt:MinimumMember 2025-09-30 0001420924 srt:MaximumMember 2025-09-30 0001420924 2024-01-01 2024-12-31 0001420924 2023-01-01 2023-12-31 0001420924 2025-05-27 2025-05-27 0001420924 ADTI:TheBallengeeGroupLLCMember ADTI:AgentCommissionsOnMLBContractsMember 2025-07-01 2025-09-30 0001420924 ADTI:TheBallengeeGroupLLCMember ADTI:MarketingIncomeMember 2025-07-01 2025-09-30 0001420924 ADTI:TheBallengeeGroupLLCMember 2025-07-01 2025-09-30 0001420924 ADTI:BacchusCapitalTradingMember 2019-04-20 0001420924 ADTI:BacchusCapitalTradingMember 2019-04-20 2019-04-20 0001420924 ADTI:WhiteClawCrudeMember 2025-07-01 2025-09-30 0001420924 ADTI:WhiteClawCrudeMember 2024-04-01 2025-03-31 0001420924 us-gaap:NonrelatedPartyMember 2025-04-01 2025-09-30 0001420924 us-gaap:NonrelatedPartyMember ADTI:NoteOneConvertibleNotesPayableMember 2025-09-30 0001420924 us-gaap:NonrelatedPartyMember ADTI:NoteOneConvertibleNotesPayableMember 2025-03-31 0001420924 us-gaap:NonrelatedPartyMember ADTI:NoteTwoConvertibleNotePayableMember 2025-09-30 0001420924 us-gaap:NonrelatedPartyMember ADTI:NoteTwoConvertibleNotePayableMember 2025-03-31 0001420924 ADTI:NoteOneConvertibleNotesPayableMember ADTI:VendorMember 2024-10-15 0001420924 ADTI:NoteOneConvertibleNotesPayableMember ADTI:VendorMember 2024-10-15 2024-10-15 0001420924 ADTI:VendorMember ADTI:NoteOneConvertibleNotesPayableMember 2025-09-30 0001420924 ADTI:VendorMember ADTI:NoteOneConvertibleNotesPayableMember 2025-03-31 0001420924 ADTI:VendorMember ADTI:NoteOneConvertibleNotesPayableMember 2025-11-01 2025-11-30 0001420924 ADTI:NoteTwoConvertibleNotePayableMember ADTI:VendorMember 2025-04-23 0001420924 ADTI:VendorMember ADTI:NoteTwoConvertibleNotePayableMember 2025-09-30 0001420924 ADTI:VendorMember ADTI:NoteTwoConvertibleNotePayableMember 2025-03-31 0001420924 ADTI:NoteTwoConvertibleNotePayableMember ADTI:VendorMember 2025-04-23 2025-04-23 0001420924 us-gaap:RelatedPartyMember 2025-04-01 2025-09-30 0001420924 ADTI:CampbellTrustMember 2025-09-30 0001420924 ADTI:CampbellTrustMember 2025-03-31 0001420924 ADTI:StuffInternationalMember 2025-09-30 0001420924 ADTI:StuffInternationalMember 2025-03-31 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertiblePromissoryNoteMember 2025-09-15 2025-09-15 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertiblePromissoryNoteMember 2025-09-15 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertiblePromissoryNoteMember 2025-11-05 2025-11-05 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableOneMember 2025-09-24 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableOneMember 2025-09-24 2025-09-24 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableOneMember 2025-09-30 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableOneMember 2025-03-31 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableOneMember 2025-11-01 2025-11-30 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableTwoMember 2024-10-24 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableTwoMember 2024-10-24 2024-10-24 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableTwoMember 2025-09-30 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableTwoMember 2025-03-31 0001420924 us-gaap:RelatedPartyMember ADTI:ConvertibleNotesPayableTwoMember 2025-11-01 2025-11-30 0001420924 ADTI:CampbellTrustMember ADTI:ConvertibleNotesPayableOneMember 2025-09-30 0001420924 ADTI:CampbellTrustMember ADTI:ConvertibleNotesPayableTwoMember 2025-09-30 0001420924 ADTI:BSGHoldeingsLLCMember 2025-09-30 0001420924 ADTI:JBAHHoldingsLLCMember 2025-09-30 0001420924 ADTI:JBAHHoldingsLLCMember 2025-03-31 0001420924 ADTI:CampbellTrustMember ADTI:NotesPayableMember 2025-06-02 0001420924 ADTI:CampbellTrustMember ADTI:NotesPayableMember 2025-09-30 0001420924 ADTI:StuffInternationalMember ADTI:NotesPayableMember 2025-09-30 0001420924 ADTI:StuffInternationalMember ADTI:NotesPayableMember 2025-03-31 0001420924 ADTI:MarketGroupInternationalMember ADTI:NotesPayableMember us-gaap:CommonStockMember 2025-03-31 2025-03-31 0001420924 ADTI:MarketGroupInternationalMember ADTI:NotesPayableMember 2025-03-31 0001420924 ADTI:MarketGroupInternationalMember ADTI:NotesPayableMember 2025-03-31 2025-03-31 0001420924 ADTI:RobertVanBoreumMember 2025-09-30 0001420924 ADTI:RobertVanBoreumMember 2025-03-31 0001420924 ADTI:AdamNicosiaMember us-gaap:CommonStockMember 2025-09-30 0001420924 ADTI:AdamNicosiaMember us-gaap:CommonStockMember 2025-03-31 0001420924 ADTI:EdgewareEnergyMember 2025-09-30 0001420924 ADTI:EdgewareEnergyMember 2025-03-31 0001420924 ADTI:JorganDevelopmentLLCMember 2025-09-30 0001420924 ADTI:JorganDevelopmentLLCMember 2025-03-31 0001420924 ADTI:EdgewareEnergyMember 2025-04-01 2025-09-30 0001420924 ADTI:LoanAndSecurityAgreementMember 2020-03-02 2020-03-02 0001420924 ADTI:LoanAndSecurityAgreementMember 2020-03-02 0001420924 ADTI:LoanAndSecurityAgreementMember 2022-05-31 2022-05-31 0001420924 ADTI:LoanAndSecurityAgreementMember 2025-06-27 2025-06-27 0001420924 ADTI:LoanAndSecurityAgreementMember us-gaap:SubsequentEventMember 2025-10-03 2025-10-03 0001420924 ADTI:BrassingtonMember 2025-09-30 0001420924 ADTI:BrassingtonMember 2025-03-31 0001420924 srt:ChiefFinancialOfficerMember 2025-08-14 0001420924 srt:ExecutiveVicePresidentMember 2025-08-14 0001420924 srt:ChiefExecutiveOfficerMember 2025-08-14 0001420924 ADTI:JBAHHoldingsLLCMember 2025-04-01 2025-09-30 0001420924 ADTI:SmallBusinessAdministrationMember 2025-09-30 0001420924 ADTI:SmallBusinessAdministrationMember 2025-03-31 0001420924 ADTI:EIDLMember 2025-09-30 0001420924 ADTI:EIDLMember 2025-03-31 0001420924 ADTI:EIDLMember 2020-04-21 2020-04-21 0001420924 us-gaap:RestrictedStockMember 2025-07-01 2025-09-30 0001420924 us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001420924 ADTI:MarketGroupInternationalMember 2025-03-31 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPapovMember 2024-10-01 2024-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:StevenDavisMember 2024-10-01 2024-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:StevenDavisMember 2024-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2024-04-01 2024-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2024-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPapovMember 2024-01-01 2024-03-31 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2024-01-01 2024-03-31 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2024-03-31 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPapovMember 2023-10-01 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPopovMember 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPopovMember 2023-10-01 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-10-01 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-10-01 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:MarketGroupInternationalMember 2023-10-01 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:MarketGroupInternationalMember 2023-12-31 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPapovMember 2023-07-01 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:VasvilPapovMember 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:VasilPopovMember 2023-07-01 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-07-01 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-07-01 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-09-30 0001420924 us-gaap:RestrictedStockMember ADTI:MarketGroupInternationalMember 2023-07-01 2023-09-30 0001420924 ADTI:PaulKisonMember 2023-04-01 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:VasilPopovMember 2023-04-01 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:VasilPopovMember 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-04-01 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:EcoScientificLabsMember 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-04-01 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:JahannesenConsultingIncMember 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:MarketGroupInternationalMember 2023-04-01 2023-06-30 0001420924 us-gaap:RestrictedStockMember ADTI:MarketGroupInternationalMember 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-03-31 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-03-31 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-03-31 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-03-31 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-03-31 0001420924 us-gaap:CommonStockMember ADTI:PaulKisonMember 2023-04-05 2023-04-05 0001420924 us-gaap:CommonStockMember ADTI:PaulKisonMember 2023-04-05 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-06-30 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-06-30 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-06-30 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-06-30 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-06-30 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-08-29 2023-08-29 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-08-29 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-09-30 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-09-30 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-09-30 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-09-30 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-09-30 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleOneMember 2023-10-27 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleOneMember 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleTwoMember 2023-10-27 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleTwoMember 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleThreeMember 2023-10-27 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:OCSparkleThreeMember 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:CZAIncMember 2023-10-27 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:CZAIncMember 2023-10-27 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-12-31 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-12-31 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-12-31 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-12-31 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:JohannesenConsultingIncMember 2023-12-31 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2024-03-31 2024-03-31 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2024-03-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2024-03-31 2024-03-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2024-03-31 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2024-06-30 2024-06-30 0001420924 us-gaap:CommonStockMember ADTI:EcoScientificLabsMember 2024-06-30 0001420924 us-gaap:CommonStockMember ADTI:SDLawGroupMember 2024-12-31 2024-12-31 0001420924 us-gaap:CommonStockMember ADTI:SDLawGroupMember 2024-12-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2024-12-31 2024-12-31 0001420924 us-gaap:CommonStockMember ADTI:VasilPopovMember 2024-12-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2025-03-31 2025-03-31 0001420924 us-gaap:CommonStockMember ADTI:MarketGroupInternationalMember 2025-03-31 0001420924 us-gaap:CommonStockMember 2025-06-30 2025-06-30 0001420924 us-gaap:CommonStockMember ADTI:JBAHHoldingsLLCMember 2025-07-01 2025-07-01 0001420924 us-gaap:CommonStockMember ADTI:JBAHHoldingsLLCMember 2025-07-01 0001420924 us-gaap:CommonStockMember ADTI:BSGHoldingsLlcMember 2025-07-14 2025-07-14 0001420924 us-gaap:CommonStockMember ADTI:BSGHoldingsLlcMember 2025-07-14 0001420924 us-gaap:SubsequentEventMember srt:MaximumMember 2025-11-06 0001420924 us-gaap:SubsequentEventMember srt:MaximumMember ADTI:JamesBallengeeMember 2025-11-06 0001420924 us-gaap:SubsequentEventMember 2025-11-30 2025-11-30 0001420924 us-gaap:SubsequentEventMember 2025-11-30 0001420924 us-gaap:SubsequentEventMember srt:ChiefExecutiveOfficerMember 2025-11-30 2025-11-30 0001420924 us-gaap:SubsequentEventMember srt:ChiefExecutiveOfficerMember 2025-11-30 0001420924 us-gaap:SubsequentEventMember srt:ExecutiveOfficerMember 2025-11-30 2025-11-30 0001420924 us-gaap:SubsequentEventMember srt:ExecutiveOfficerMember 2025-11-30 0001420924 us-gaap:SubsequentEventMember 2025-11-05 0001420924 us-gaap:SubsequentEventMember 2025-11-05 2025-11-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ADTI:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED: ~~JUNE~~SEPTEMBER 30, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-53336

Adapti, Inc.

(Exact name of registrant as specified in its charter)

Nevada

01-0884561

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2278 Monitor St,

Dallas, Texas

85004

(Address of Principal Executive Offices)

(Zip Code)

775-375-1500

Registrant’s telephone number

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐

Non-accelerated filer ☐		Smaller reporting company ☒

		Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of common stock ($0.001 par value) outstanding as of ~~August~~November 1419, 2025 was 8,039,259.

Adapti, Inc.

Table of Contents

		Page
PART I	FINANCIAL STATEMENTS (unaudited)	3
Item 1.	Condensed Balance Sheets	3
	Condensed Statements of Operations	4
	Statements of Changes in Stockholder Deficit	5
	Condensed Statements of Changes in Stockholders’ Deficit	5
	Condensed Statements of Cash Flow	6
	Condensed Statements of Cash Flows	6
	Notes to Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2031
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	2436
Item 4.	Controls and Procedures	2436
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	2537
Item 1A.	Risks Factors	2537
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3446
Item 3.	Defaults Upon Senior Securities	3546
Item 4.	Mine Safety Disclosures	3546
Item 5.	Other Information	3546
Item 6.	Exhibits	3647
SIGNATURES		3748

PART I

FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Adapti, Inc.

Condensed Balance Sheets

	June 30,			March 31,
	September 30,			March 31,
	2025			2025
ASSETS
Current Assets:
Cash	$	891,~~863~~540,411		$	572
Accounts receivable		~~696~~59,766			640
TOTAL ASSETS	$	90,559		$	1,212
Prepaid expenses		11,432			-
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Contracts receivable- current		3,432,685			-
ROU Current Asset		300,000			-
Total Current Assets		5,344,294			1,212
Fixed assets, net		-			-
Contracts receivable- long term		3,425,000			-
ROU Asset - long term		742,464			-
Value of future contracts		19,180,000			-
Intangible asset - brand name		5,956,401			-
Total Long Term Assets	$	29,303,866		$	-
TOTAL ASSETS	$	34,648,159		$	1,212
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities:
Accounts payable and accrued liabilities	$	~~673~~1,~~260~~335,810		$	525,618
Convertible notes payable, accrued interest		~~277~~284,~~967~~520			52,745
Related party convertible notes payable, accrued interest		~~217~~405,~~096~~029			211,113
Related party notes payable, accrued interest		248,077			242,511
Convertible notes payable, accrued interest		405,029			211,113
Total Current Liabilities		1,416,401			1,031,987
Related party notes payable, accrued interest		513,704			242,511
EIDL Loans		7,000			7,000
Commissions payable, current		2,341,989			-
Total Long - Term Liabilities		7,000			7,000
Due to related party		583,024			-
Total Liabilities		1,423,401			1,038,987
Line of credit		361,272			-
Stockholders’ Deficit:
Operating lease liability, current		300,000			-
Preferred Stock, par value $0.001, authorized 20,000,000 issued zero at June 30, 2025 and March 31, 2025, respectively		-			-
Total Current Liabilities		6,125,348			1,031,987
Common stock, $0.001 par value, Authorized 200,000,000, 1,539,259 and 1,532,388 shares outstanding at June 30, 2025 and March 31, 2025, respectively		1,539			1,532
Related party convertible notes payable, long term		2,169,881			-
Additional paid-in capital		8,473,080			8,473,086
Related party convertible note Payable, long term		7,580,137			-
Accumulated deficit		(9,807,460	)		(9,512,394	)
Commissions payable, long term		1,871,586			-
Total Stockholders’ Deficit		(1,332,842	)		(1,037,775	)
Operating lease liability, long term		742,464			-
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	90,559		$	1,212
EIDL Loans		87,900			7,000
Total Long - Term Liabilities		12,451,968			7,000
Total Liabilities		18,577,316			1,038,987
Stockholders’ Equity (Deficit):
Preferred Stock, par value $0.001, authorized 20,000,000 issued zero at September 30, 2025 and March 31, 2025, respectively		-			-
Common stock, $0.001 par value, authorized 40,000,000,000, 8,039,259 and 1,532,388 shares outstanding at September 30, 2025 and March 31, 2025, respectively		8,039			1,532
Additional paid-in capital		28,466,580			8,473,086
Accumulated deficit		(12,403,776	)		(9,512,394	)
Total Stockholders’ Equity (Deficit)		16,070,843			(1,037,775	)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	34,648,159		$	1,212

See accompanying notes to the condensed financial statements.

Adapti, Inc.

Condensed Statements of Operations

	For the Three Months Ended
	Three Months Ended						For the Six Months Ended
	June 30,
	September 30,						September 30,
	2025			2024			2025			2024
Revenues	$	~~664~~2,131,437		$	~~948~~2,030		$	2,132,101		$	2,978
Cost of revenue		-1,333,525			-			1,333,525			-
Gross Profit		~~664~~797,912			~~948~~2,030			798,576			2,978
Operating Expenses
General and administrative	$	47590,~~251~~744		$	464,~~090~~390		$	637,994		$	50,480
Professional fees		~~231~~2,~~707~~620,086			~~223~~138,~~968~~955			2,851,793			362,923
Total Operating Expenses		~~278~~3,~~958~~210,830			~~270~~143,~~058~~345			3,489,787			413,403
Loss from operations		(~~278~~2,~~294~~412,918	)		(~~269~~141,~~110~~315	)		(2,691,211	)		(410,425	)
Other Expense
Interest expense	$	(16183,~~771~~400	)	$	(910,~~723~~727	)	$	(200,171	)	$	(20,450	)
Net Other Expense		(16183,~~771~~400	)		(910,~~723~~727	)		(200,171	)		(20,450	)
Net Loss	$	(~~295~~2,~~065~~596,318	)	$	(~~278~~152,~~833~~042	)	$	(2,891,382	)	$	(430,875	)
Net Loss Per Common Share: Basic and Diluted	$	(0.~~192~~28	)	$	(0.~~189~~10	)	$	(0.538	)	$	(0.288	)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted		19,~~539~~169,~~259~~694			1,~~472~~493,~~722~~972			5,371,908			1,493,972

See accompanying notes to the condensed financial statements.

Adapti, Inc.

~~Statements~~Condensed Statements of Changes in Stockholders’ Deficit

For the Three and Six Months ended ~~June~~September 30, 2025 and 2024

					Additional						Total
	Common Stock				Additional						Total
	Common Stock				Paid-in			Accumulated			Stockholders’
	Number of Shares		Amount		Paid-in Capital			Accumulated Deficit			Stockholders’ Deficit
	Number of Shares		Amount		Capital			Deficit			Deficit
Balance - March 31, 2024 - Audited		1,483,555	$	1,484	$	8,060,004		$	(8,552,249	)	$	(490,760	)
Balance - March 31, 2024		1,483,555	$	1,484	$	8,060,004		$	(8,552,249	)	$	(490,760	)
Common shares issued for stock compensation		10,417		10		95,823			-			95,834
Net loss		-		-		-			(278,833	)		(278,833	)
Balance - June 30, 2024		1,493,972	$	1,494	$	8,155,827		$	(8,831,082	)	$	(673,759	)
Balance - March 31, 2025		1,532,388	$	1,532	$	8,473,086		$	(9,512,394	)	$	(1,037,775	)
Common shares issued for stock compensation		-		-		-			-			-
Stock Split Reconciliation		6,871		7		(-7	)		-			-
Net loss		-		-		-			(152,042	)		(152,042	)
Balance - September 30, 2024		1,493,972	$	1,494	$	8,155,827		$	(8,983,124	)	$	(825,801	)
Balance - March 31, 2024 - Audited		1,483,555	$	1,484	$	8,060,004		$	(8,552,249	)	$	(490,760	)
Common shares issued for stock compensation		10,417		10		95,823			-			95,834
Net loss		-		-		-			(430,875	)		(430,875	)
Balance - September 30, 2024		1,493,972	$	1,494	$	8,155,827		$	(8,983,124	)	$	(825,801	)
Balance - March 31, 2025 Audited		1,532,388	$	1,532	$	8,473,086		$	(9,512,394	)	$	(1,037,775	)
Adjustment		6,871		7		(7	)		-			-
Net loss		-		-		-			(295,066	)		(295,066	)
Balance - June 30, 2025		1,539,259	$	1,539	$	8,473,079		$	(9,807,460	)	$	(1,332,841	)
Common shares issued for acquisition		6,500,000		6,500		19,993,500			-			20,000,000
Net loss		-		-		-			(2,596,318	)		(2,596,318	)
Balance - September 30, 2025		8,039,259	$	8,039	$	28,466,580		$	(12,403,776	)	$	16,070,843
Balance - March 31, 2025 Audited		1,532,388	$	1,532	$	8,473,086		$	(9,512,394	)	$	(1,037,775	)
Balance		1,532,388	$	1,532	$	8,473,086		$	(9,512,394	)	$	(1,037,775	)
Adjustment		6,871		7		(7	)		-			-
Common shares issued for acquisition		6,500,000		6,500		19,993,500			-			20,000,000
Net loss		-		-		-			(2,891,382	)		(2,891,382	)
Balance - September 30, 2025		8,039,259	$	8,039	$	28,466,580		$	(12,403,776	)	$	16,070,843
Balance		8,039,259	$	8,039	$	28,466,580		$	(12,403,776	)	$	16,070,843

See accompanying notes to the condensed financial statements.

Adapti, Inc.

Condensed Statements of Cash Flows

	(unaudited)
	For the six months ended
	For the Period ended
	September 30,
	June
	2025			2024
OPERATING ACTIVITIES:
Net loss	$	(~~295~~2,~~065~~891,382	)	$	(~~278~~430,~~833~~875	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock based compensation		-			95,832
Accounts receivable		~~(57~~24	)		~~1,100~~997
Accrued interest		16,771			9,723
Prepaid Expenses		5,716			-
Accounts payable and accrued liabilities		167,642			172,353
Contracts receivable		1,657,420			-
Net Cash provided by (used in) operating activities		(110,709	)		176
Accrued interest		112,710			20,450
Commissions payable		(279,182	)		-
Accounts payable and accrued liabilities		791,243			145,625
Net Cash Provided by (used in) Operating Activities		(603,450	)		(167,970	)
INVESTING ACTIVITIES:
Net Cash Used in Investing Activities		-			-
Proceeds from related party notes payable		150,000			-
Advances Jorgan Development		107,000			-
Net Cash Used in Investing Activities		257,000			-
FINANCING ACTIVITIES:
Proceeds from notes payable		200,000			-
Net cash (payments) proceeds line of credit		(150,000	)		-
Net Cash Provided by Financing Activities		200,000			-
Issuance of related party convertible notes payable		2,156,000			-
Net decrease in cash		89,291			176
Net contributions from BSG		(319,711	)		-
Proceeds/Issuance of/from notes payable		200,000			203,431
Net Cash Provided by Financing Activities		1,886,289			203,431
Net decrease in cash		1,539,839			35,461
Cash, beginning of period		572			702
Cash, end of period	$	891,~~863~~540,411			~~878~~36,163
Supplemental cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash transactions:
Issuance of note payable	$	220,000		$	70,418
Issuance of convertible Notes Payable	$	150,000		$	100,000
Issuance of note payable	$	7,700,000		$	103,431

See accompanying notes to the condensed financial statements.

NOTE 1. ORGANIZATION AND NATURE OF BUSINESS

Adapti, Inc. (the “Company”) was incorporated in the State of Nevada on January 11, 2007. ~~The~~After undergoing several name changes, the Company changed its name to Adapti, Inc. on April 15, 2025, to reflect a strategic shift in focus away from health and beauty product sales and toward a technology-driven company operating in the sports management, marketing, and athlete representation industries.

InOn July 14, 2025, the Company completed the acquisition of The Ballengee Group, LLC (Ballengee”), a sports management agency representing approximately 200 professional athletes, 40 of which play Major League baseball. Ballengee primarily markets through a boots-on-ground model, with a team of five scouts covering the high school and collegiate athlete markets across the southern United States and Sunbelt region.

The Company is currently developing its technology platform, ~~adapt~~AdaptAI.~~io.~~ ~~Adapti.io~~AdaptAI, is a proprietary AI-driven tool designed to identify optimal alignment between brands and social media influencers. The platform, when completed, will create a data fingerprint for each athlete or brand, enabling precise matching with influencers whose audience and engagement metrics are best suited for targeted marketing campaigns. ~~Adapt.io~~ AdaptAI is being designed to continually analyze proprietary data for each specific marketing campaign along with public data sources as additional feedback to inform ongoing promotion. This strategic alignment is intended to maximize exposure and sponsorship value for its influencer and athlete clients, while maximizing response rates for partner brands. The ~~adapti.io~~AdaptAI tool is currently in the beta stage of development. We anticipate launching ~~adapti.io~~AdaptAI by ~~the~~December ~~end of March~~ 31, 2026, subject to the Company securing sufficient funding.

With its ~~with its~~ recent acquisition of Ballengee Group, the Company is focused on integrating the operations of the Ballengee Group and with ~~its~~the ~~athletes~~Company.

While ~~adapt.io~~AdaptAI is currently being developed exclusively for brand and influencer matching, the Company plans to eventually expand ~~Adapti.io~~AdaptAI’s capabilities to support automated content creation and enable end-to-end generative content workflows for social media publishing and campaign execution. The Company believes that these future capabilities will ~~streamline~~assist in streamlining the production and distribution of high-performing digital content across client campaigns.

The Company has ceased its efforts to market or sell health and beauty products, including the Dermacia brand, and subject to potential sales for retained inventory through its channels, will no longer be generating revenue from those lines. Future revenues are expected to be derived primarily from athlete representation fees, sponsorships, and platform-enabled brand integrations, utilizing the AdaptAI platform, when it is completed and operational.

Reverse Stock Split

Effective May 28, 2025, the Company effected a 1-for-4,000 reverse stock split of our issued and outstanding common stock (the “Reverse Stock Split”). As a result of the Reverse Stock Split, our stockholders received one share of our common stock for every 4,000 shares held immediately prior to the effective time of the Reverse Stock Split. Unless otherwise noted, all common stock shares, common stock per share data and shares of common stock underlying convertible instruments included in this Quarterly Report on Form 10-Q, including the exercise or conversion price of such convertible instruments, as applicable, have been retrospectively adjusted to reflect the Reverse Stock Split.

NOTE 2. GOING CONCERN

The Company accounts for going concern matters under the guidance of ASU 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (“ASU 2014-15”). The guidance in ASU 2014-15 sets forth management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity’s ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management’s plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt.

These financial statements have been prepared on a going concern basis which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As of ~~June~~ September 30, 2025, the Company has incurred losses totaling $912,~~807~~403,~~460~~776 (as of March 31, 2025 - $9,512,394) since inception, has not yet generated significant revenue from its operations, and will require additional funds to maintain our operations. As of ~~June~~September 30, 2025, the Company had a working capital deficit of $1781,~~325,841~~054 (as of March 31, 2025 - $1,030,775) and incurred a loss for the period ended ~~June~~September 30, 2025 of $~~295~~2,~~065~~891,382 (as of March 31, 2025 - $~~278~~430,~~833~~875). The Company’s ability to continue as a going concern is dependent upon its ability to generate future ~~profitable~~ profitable operations and our ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. The Company intends to finance operating costs over the next twelve months through c the offer and sale of debt and equity securities and to a lesser extent, cash from operations. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 3. ~~SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES~~ACQUISISTIONS

The Company accounts for all business combinations in accordance with Financial Accounting Standards Board(“FASB”) ASC 805, “Business Combinations” (“ASC 805”), using the acquisition method of accounting. Under this method, assets and liabilities, including any remaining non-controlling interests, are recognized at fair value at the date of acquisition. The excess of the purchase price over the fair value of assets acquired, net of liabilities assumed, and is recognized as goodwill. Certain adjustments to the assessed fair values of the assets, liabilities, may be made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period would be recorded as income. Results of operations of the acquired entity are included in the Company’s results from operations from the date of the acquisition onward and include amortization expense arising from acquired assets. The Company expenses all costs as incurred related to an acquisition in the condensed consolidated statements of operations.

Ballengee Group

Amended and Restated Membership Interest Purchase Agreement

On July 14, 2025, the Company entered into an amended and restated membership interest purchase agreement (the “Purchase Agreement”) with BSG Holdings, LLC and JBAH Holdings, LLC (“Sellers”), pursuant to which the Company acquired, from the Sellers, 100% of the outstanding membership interests (“Membership Interests”) of Ballengee. The acquisition of the Membership Interests closed on July 14, 2025 (the “Closing Date”).

Pursuant to the Purchase Agreement, as consideration for the acquisition of the Membership Interest, the Company is required to pay the Sellers, pro rata, the following aggregate consideration (collectively, the “Consideration”): (i) 6,500,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) valued at $20,000,000, based on the volume-weighted average price per share of the common stock for the ten trading days prior to closing (the “Stock Consideration”), (ii) a participating promissory note having a principal amount of $7,500,000 (the “Note(s)”), and (iii) up to $20,000,000 in earnout consideration to paid over a four (4) year period on the achievement of certain milestones by Ballengee post-acquisition (the “Earnout Consideration”).

Participating Notes

The Notes were issued on the Closing Date and have: (i) a maturity date of September 30, 2030, and (ii) an interest rate of five percent (5%) per annum. Prior to the maturity date, the Company is required to make mandatory payments on the Notes: (i) in the event the Company completes an offering of its securities resulting in gross proceeds of at least $250,000, and (ii) from free cash flow generated by Ballengee, as a standalone entity.

Earnout Consideration

The Earnout Consideration is payable in common stock over a four (4) year period beginning on January 1, 2025 and ending on December 31, 2028 (each year, an “Earnout Year”). For each Earnout Year, based on Ballengee’s earnings before interest, taxes, depreciation and amortization (“EBITDA”), the Sellers will receive the following aggregate consideration: (i) no Earnout Consideration will be earned if EBITDA is less than $2,000,000, (ii) Earnout Consideration will equal EBITDA for EBITDA between $2,000,000 and $5,000,000, and (iii) Earnout Consideration will be $5,000,000 for EBITDA of $5,000,000 or more. The valuation of the Earnout Consideration Common Stock will be valued using the volume weighted average closing price of the Common Stock for the ten (10) trading days immediately prior to December 31 of each applicable Earnout Year.

Ballengee continued its operations uninterrupted during closing and retained certain key employees. The Purchase Agreement included customary representations, warranties and covenants of the parties.

The Company has combined the acquisition effective June 30, 2025 to simplify the accounting under ASC 805 purchase accounting as it pertains to the acquisition of the Ballengee.

The following table summarizes the provisional unaudited purchase price allocations relating to the Ballengee acquisition:

SCHEDULE OF PURCHASE PRICE ALLOCATIONS

	Preliminary
	Purchase Price
	Allocation
Cash	$	349,353
Total assets		9,704,256
Liabilities		(7,690,010	)
Net assets acquired	$	2,363,599

	Preliminary
	Purchase Price
	Allocation
Cash	$	349,353
Total assets		9,704,256
Present value of contract receivables		19,180,000
Intangible asset- brand value		5,956,401
Liabilities		(7,690,010	)
Net	$	27,500,000

The purchase price for the acquisition was allocated to the fair value of the assets acquired and liabilities assumed based on the estimates of the fair values at the acquisition date. The Company’s share price for commons stock was quoted at $3.00 per share at closing dating which represents a 19,500,000 of total common stock issued at acquisition date for 6,500,000 common shares. In addition, the company issued a $7,500,000 promissory note. The remaining amount of consideration ($500,000) was allocated to paid in capital. This represented a total consideration at acquisition date of $27,500,000.

The unaudited pro forma information set forth above is for informational purposes only. The pro forma information should not be considered indicative of actual results that would have been achieved if the Ballengee acquisition had occurred on June 30, 2025. The unaudited supplemental pro forma financial information was calculated by combining the Company’s results with the stand-alone results of Ballengee for the identified periods, which were adjusted for certain transactions and other costs that would have occurred during this pre-acquisition period.

NOTE 4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America.

All figures are in U.S. Dollars. The Company’s fiscal year ends on March 31. Any reference to the period ended September 30, 2025 relates to the three months ended on such date. Any reference to a period ended March 31, 2025 relates to the fiscal year ended on such date.

year ends on March 31. Any reference to the period ended June 30, 2025 relates to the three months ended on such date. Any reference to a period ended March 31, 2025 relates to the fiscal year ended on such date.

Reclassifications

Certain amounts in the prior period have been reclassified to conform to the current period presentation. These reclassifications have no material effect on the reported financial results

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated

~~financial~~Financial statements include, but are not limited to, stock-based compensation, derivate instruments, accounting for preferred stock, and the valuation of acquired assets and liabilities. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand and on deposit at banking institutions as well as all highly liquid short-term investments with original maturities of 90 days or less. The Company had cash on hand of $891,~~863~~540,411 as of ~~June~~September 30, 2025 and $572 as of March 31, ~~2025~~ 2025. The Company had no cash equivalents as of ~~June~~September 30, 2025 or March 31, 2025.

Revenue Recognition

Under Financial Accounting Standards Board (“FASB”) Topic 606, “Revenue from Contacts with Customers” (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the products to be sold in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the products in the contract; and (v) recognize revenues when (or as) the Company delivers the contracted product to the customer.

The Company also recognizes ~~revenue~~Major League Baseball (i“MLB”) ~~when~~Player ~~they~~Contract ~~receive~~Commissions (arbitration revenues) – Ballengee negotiates single-year and multi-year MLB contracts for its represented athletes. Ballengee, as a ~~purchase~~subsidiary ~~order~~of ~~from~~the Company, earns a commission on all salaries, incentives, and bonuses stipulated in the ~~Amazon~~contract. ~~online~~The ~~system~~MLB ~~(ii)~~contracts ~~each~~negotiated ~~purchase~~by ~~order~~Ballengee ~~identifies~~are for guaranteed contracts only. The terms of the ~~quantity~~contracts signed between the Company and ~~products~~its torepresented beathletes ~~purchased~~state ~~(iii)~~that ~~each~~the ~~purchase~~athlete ~~order~~owes ~~has~~the Company its commission whether the athlete ~~price~~remains ~~including~~Ballengee’s ~~discounts,~~client ~~(iv)~~throughout ~~there~~the term of the contract or terminates their relationship with Ballengee to pursue alternative representation. Ballengee’s only performance obligation is noto ~~requirement~~successfully ~~for~~negotiate ~~allocation~~the athlete’s contract. asAll ~~each~~minor ~~sku~~league ~~has~~and amajor ~~separate~~league ~~price~~baseball contracts are reviewed, approved and signed by the Commissioner of Baseball to ensure compliance with league rules. The MLB contract is not in effect until it is signed by the Commissioner of Baseball. A copy of the contract is sent to the Major League Baseball Players Association (vMLBPA). As Ballengee has an unconditional right to consideration, the Company, as the parent corporation of Ballengee, recognizes ~~revenue~~all ~~when~~commissions ~~the~~on ~~customer~~all ~~receives~~current and future year salaries the ~~product~~player ~~from~~will ~~Amazon~~earn ~~within~~throughout atheir ~~matter~~contract ofat ~~days~~the point in time the contract is signed into effect.

8From time to time, Ballengee will negotiate performance and award bonuses. Ballengee will recognize the revenues on those bonuses when the performance targets are achieved or they are awarded as the payments for those bonuses are guaranteed by the club and approved contractually by the MLB.

~~Accounts~~For ~~Receivable~~each contract approved by the Commissioner of Baseball, for both major league and minor league contracts, the player enter into life insurance that covers a majority of the players’ salary. If a tragic event occurs the life insurance proceeds will be paid to the Club and in certain circumstances a portion to MLB.

The Company does not currently maintain reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis. As of June 30, 2025 and March 31, 2025, the Company did not have an allowance for doubtful accounts.11

MLB Player Marketing Commissions (marketing revenues) – Ballengee negotiates and secures marketing activities (personal appearances, exhibitions/clinics, books, films, media opportunities, etc.) for its represented athletes. Ballengee earns a commission on all athlete earnings from marketing activities. The terms of the contracts signed between Ballengee and its represented athletes state that the athlete owes Ballengee its commission on marketing activities negotiated by the Company whether the athlete remains the Ballengee’s client throughout the term of the marketing contract or terminates their relationship with Ballengee to pursue alternative representation. Ballengee’s only performance obligation is to successfully negotiate a marketing contract. As the Company has an unconditional right to consideration, the Company, pursuant to its consolidation with Ballengee recognizes all commissions on all current and future year earnings from marketing activities at the point in time the contract is signed into effect. Generally, marketing contracts are short-term in nature.

For some marketing contracts it is industry standard that the player receives the full benefit for certain types of marketing activities, specifically, for personal appearances, signing baseball cards, exhibitions and clinics. The Company recognizes these events as gross revenues as they are the primary obligor in determining the pricing and timing of the event.

For marketing contracts, Ballengee exercises control over the marketing activities prior to their delivery to the player:

	1.	Responsibility and Oversight: Ballengee is responsible for the strategy, approval, and execution of the marketing campaigns. It selects and manages vendors and ensures that deliverables meet contractual objectives.

	2.	Control of the Service: Ballengee determines the design, content, and timing of marketing efforts, demonstrating control before transfer.

	3.	Pricing and Contracting: Ballengee negotiates pricing with customers and vendors separately, retaining discretion in allocation and budgetary expenses for the event.

	4.	Fulfillment Risk: If third-party vendors fail to perform, Ballengee remains responsible for performance, indicating fulfillment risk.

Ballengee’s performance obligation is to provide an integrated marketing service rather than simply arranging for another party to do so. Accordingly, Ballengee controls the specified service before transfer to the customer, further supporting reporting marketing revenues gross.

Ballengee also represents a small group of players that play internationally in Japan. The terms of these contracts are similar to the MLB minor league and major league baseball. For their international players, the Company recognizes revenue in the same manner as their minor league and major league baseball contracts.

Disaggregation of Ballengee Revenue:

Ballengee disaggregates revenue based on the type of service and timing of revenue recognition. For the three months ended September 30, 2025, revenue was as follows:

SCHEDULE OF DISAGGREGATION OF REVENUE


Agent Commissions on MLB Contracts:	$	2,020,591

Marketing Income		102,335

Total Ballengee revenue:	$	2,122,926

In cost of revenues, Ballengee has recorded expenses related to marketing income of $70,749 for the three months ended September 30, 2025. The balance of expenses in cost of revenues pertains to client expenses in the amount of $73,363 for the three months ended September 30, 2025, respectively.

The Company also recognizes revenue (i) when they receive a purchase order from the Amazon online system (ii) each purchase order identifies the quantity and products to be purchased (iii) each purchase order has the price including discounts, (iv) there is no requirement for allocation as each sku has a separate price, and (v) the Company recognizes revenue when the customer receives the product from Amazon within a matter of days.

Major Customers and Concentration of Credit Risk

The foundation of the Company relies on the relationships that Ballengee’s agents have with current MLB players, including minor league players. During 2024, we had ten agents, of which five of those agents handled 90% of our Ballengee’s revenue and contracts. In 2023, we had ten agents handling 90% or more of our revenues and contracts. The value of the bull pen is also tied to our agent relationships with up-and-coming baseball players. Subsequent to March 31, 2025, we parted with one of our agents that had significant client relationships. We are currently evaluating the impact of this event on our business. The Company evaluates industry specific credit risk but does not believe that any material risk is identified that could materially impact on our results of operations and financial position.

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company places its cash with high quality banking institutions. From time to time, the Company may maintain cash balances at certain institutions in excess of the Federal Deposit Insurance Corporation limit of $250,000. The Company has not incurred any loss from this risk, nor does it expect it to. The Company’s revenues from product sales and accounts receivable have no material or significant concentration in anyone or a multitude of customers and all receivables are expected to be collected.

Accounts Receivable and Allowances

For Adapti, the Company does not currently maintain reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis. As of September 30, 2025 and March 31, 2025, the Company did not have an allowance for doubtful accounts.

For Ballengee, the Company’s trade accounts receivable are primarily derived from revenues earned on marketing agreements entered into by the athletes being represented and the commissions on the current year salary that athletes earn. At each balance sheet date, the Company recognizes an expected allowance for credit losses. In addition, also at each reporting date, this estimate is updated to reflect any changes in credit risk since the receivable was initially recorded. This estimate is calculated on a pooled basis where similar risk characteristics exist. Historically, the Company has had no credit losses as the MLB minor league and major league contracts are guaranteed.

The allowance estimate is derived from a review of the Company’s historical losses based on the aging of receivables. This estimate is adjusted for management’s assessment of current conditions, reasonable and supportable forecasts regarding future events, and any other factors deemed relevant by the Company. The Company believes historical loss information is a reasonable starting point in which to calculate the expected allowance for credit losses as the Company’s portfolio segment, represented athletes, has remained constant since the Company’s inception. The allowance for credit losses for trade accounts receivable was $32,839 as of September 30, 2025. The Company felt that since all receivables were able to be collected, there was no need for an additional allowance in 2025 but kept the same allowance to be conservative.

When Ballengee negotiates athlete contracts and they are signed into effect by the Commissioner of Major League Baseball, Ballengee earns revenues on all current and future year salaries stipulated in the contract that will be paid to the athlete, which is guaranteed. Ballengee sends an invoice in August to remind the teams to pay the fees owed to players and the agents that work for Ballengee.

The Company recognizes the current portion of the contracts receivable to be collected in the next twelve months.

Equipment

Equipment is carried at cost, less accumulated depreciation. Depreciation of equipment is provided using the straight-line method over the estimated useful lives of the assets. Estimated useful lives of property and equipment are 3-7 years.

Routine maintenance and repairs are charged to operating expense, while the costs of improvements and replacements are capitalized. When an asset is retired or sold, its cost and related accumulated depreciation are removed from the accounts, and the difference between the net book value of the asset and proceeds from disposition is recognized as a gain or loss in the statement of operations.

Commissions payable

Commissions payable consist of the portion of commissions earned on current year athlete salaries that are due to the Ballengee’s agents. The Company records commissions payable to Ballengee agents, and the related commission expense, in the year that the salary will be paid to the athlete. Commissions are accrued at the time the player contracts are officially signed and approved by the MLB Commissioner. Agent commissions are guaranteed and are to be paid even if the agent leaves the agency, which is also industry standard.

The Company recognizes the current portion of the commissions payable in the next twelve months.

Convertible Debt

When the Company issues convertible debt, it first evaluates the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480, Distinguishing Liabilities from Equity, and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a standalone instrument, meets the definition of an “embedded derivative” in ASC 815, Derivatives and Hedging. Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the consolidated balance sheet at fair value, with any changes in its fair value recognized currently in the consolidated statements of operations.

Stock-Based Compensation

ASC 718, “Compensation - Stock Compensation”, prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity - Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

914

Income Taxes

WeAdapti ~~account~~accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are recorded, when necessary, to reduce deferred tax assets to the amount expected to be realized.

~~ASC~~Ballengee ~~740~~Group, ~~Income~~LLC ~~Taxes~~is ~~(“ASC~~organized ~~740”), which clarifies the accounting and disclosure for uncertainty in tax positions,~~ as ~~defined, seeks~~a tolimited ~~reduce~~liability ~~the~~company ~~diversity~~under ~~in practice associated with certain aspects of~~ the ~~recognition~~laws ~~and measurement related to accounting for income taxes. We adopted the provisions~~ of ~~ASC~~Texas ~~740 as of January 1, 2007~~ and ~~have~~is ~~analyzed~~treated ~~filing positions in each of the federal and state jurisdictions where we are required to file income tax returns,~~ as ~~well~~a aspass-through ~~all~~entity ~~open~~for ~~tax years in these jurisdictions. We have identified the~~ U.S. federal and ~~California~~state asincome ~~our “major”~~ tax ~~jurisdictions~~purposes. ~~With~~As ~~limited~~a ~~exceptions~~pass-through entity, weBallengee’s ~~remain~~income, ~~subject~~deductions, tocredits, ~~Internal Revenue~~and ~~Service~~other ~~(“IRS”) examination of our income~~ tax ~~returns~~attributes ~~filed~~are generally ~~within~~passed ~~the~~through ~~last~~to ~~three~~its ~~(3) years~~members, ~~and~~who toreport ~~California~~their ~~Franchise Tax~~respective ~~Board~~shares ~~examination~~ of ~~our income tax returns filed within~~ the ~~last~~Company’s ~~four~~taxable ~~(4)~~income ~~years.~~or ~~However,~~loss weon ~~have~~their ~~certain tax attribute carryforwards~~individual ~~which~~or ~~will~~corporate ~~remain~~tax ~~subject~~returns. toAccordingly, ~~review~~Ballengee ~~and~~does ~~adjustment~~not byrecord ~~the~~a ~~relevant~~provision ~~tax~~for ~~authorities~~federal ~~until~~or ~~the~~state ~~statute~~income oftaxes ~~limitations~~in ~~closes~~its ~~with~~financial ~~respect~~statements, toas ~~the~~income ~~year~~tax inobligations ~~which~~are ~~such~~borne ~~attributes~~by ~~are~~the ~~utilized~~members.

~~For~~ASC 740, ~~the~~Income ~~periods~~Taxes ~~ended June~~(“ASC 30740”), ~~2025~~which clarifies the accounting and ~~March~~disclosure 31for uncertainty in tax positions, ~~2025~~as defined, seeks to reduce the ~~Company~~diversity ~~recognized~~in apractice ~~full~~associated ~~valuation~~with ~~allowance~~certain ~~against~~aspects of the ~~recorded~~recognition ~~deferred~~and measurement related to accounting for income taxes. We adopted the provisions of ASC 740 as of January 1, 2007 and have analyzed filing positions in each of the federal and state jurisdictions where we are required to file income tax ~~assets~~returns, as well as all open tax years in these jurisdictions.

WeAccounting believe that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to our financial position. Therefore, no reserves for ~~uncertain~~Tax income tax positions have been recorded pursuant to ASC 740. Our policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.Positions

For Adapti, we have identified the U.S. federal and California as our “major” tax jurisdictions. With limited exceptions, we remain subject to Internal Revenue Service (“IRS”) examination of our income tax returns filed within the last three (3) years, and to California Franchise Tax Board examination of our income tax returns filed within the last four (4) years. However, we have certain tax attribute carryforwards which will remain subject to review and adjustment by the relevant tax authorities until the statute of limitations closes with respect to the year in which such attributes are utilized. For the periods ended September 30, 2025 and March 31, 2025, the Company recognized a full valuation allowance against the recorded deferred tax assets.

For Ballengee, we believe that our income tax filing positions and deductions will be sustained on audit and do not anticipate any adjustments that will result in a material change to our financial position. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. Our policy for recording interest and penalties associated with income-based tax audits is to record such items as a component of income taxes.

Ballengee follows the provisions of ASC 740, Income Taxes, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. Under ASC 740, a tax position is recognized in the financial statements when it is more likely than not (i.e., a likelihood of more than 50%) that the position will be sustained upon examination by tax authorities, based on the technical merits of the position. Recognized tax positions are measured at the largest amount of benefit that has a greater than 50% likelihood of being realized upon settlement. As a pass-through entity, the Company generally does not incur entity-level income tax liabilities. However, the Company evaluates any uncertain tax positions related to its operations, including those that may affect the members’ tax reporting or result in entity-level taxes in certain jurisdictions (e.g., state taxes, franchise taxes, or taxes in jurisdictions where pass-through status may not be fully recognized).

As of December 31, 2024, the Company has evaluated its tax positions and determined that there are no material uncertain tax positions requiring recognition or disclosure in the financial statements. The Company has not recorded any liabilities for unrecognized tax benefits, interest, or penalties related to uncertain tax positions.

Other Tax Considerations

The Company may be subject to certain state or local taxes, such as franchise taxes, gross receipts taxes, or other non-income-based taxes, which are recorded as operating expenses in the financial statements in accordance with ASC 720, Other Expenses.

For Ballengee, for the years ended December 31, 2024 and 2023, the Company incurred $256,801 and $214,935, respectively, in such taxes, which are included in administrative expenses. The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. As of December 31, 2024 and 2023, the Company’s tax returns for the years 2021 to 2024 remain subject to examination by the relevant tax authorities. The Company is not currently under examination by any tax authority.

Net Loss per Share

The Company follows ASC 260, “Earnings per Share” (“EPS”), which requires presentation of basic EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation. In the accompanying financial statements, basic earnings (loss) per share are computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.

Diluted earnings per share reflects the potential dilution that could occur if securities were exercised or converted into common stock or other contracts to issue common stock resulting in the issuance of common stock that would then share in the Company’s earnings subject to anti-dilution limitations. In a period in which the Company has a net loss, all potentially dilutive securities are excluded from the computation of diluted shares outstanding as they would have an anti-dilutive impact.

For the periods ended ~~June~~September 30, 2025 and March 31, 2025, potentially dilutive common shares consist of common stock issuable upon the conversion of convertible notes payable. All potentially dilutive securities were excluded from the computation of diluted weighted average number of shares of common stock outstanding as they would have had an anti-dilutive impact.

On May 27, 2025, the Company received approval from FINRA for a number of corporate actions including a name change from Scepter Holdings, Inc. to Adapti, Inc., a 1-for-4,000 reverse stock split and a symbol change to ADTI. The name change was effective ~~immediately,~~on such date and the reverse split took effect on May 28, 2025 and the symbol change took effect on June 25, 2025.

Contingencies

The Company follows ASC 450-20, “Loss Contingencies” to report accounting for contingencies. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. There were no loss contingencies as of ~~June~~September 30, 2025 and March 31, 2025.

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”) which supersedes existing guidance on accounting for leases in “Leases (Topic 840).” The standard requires lessees to recognize the assets and liabilities that arise from leases on the balance sheet. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. The new guidance is effective for annual reporting periods beginning after December 15, 2018 and interim periods within those fiscal years. The amendments should be applied at the beginning of the earliest period presented using a modified retrospective approach with earlier application permitted as of the beginning of an interim or annual reporting period. The Company evaluated the effects of adopting ASU 2016-02 on its consolidated financial statements and determined that the Company currently has no leases for valuation.

1016

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU enhances the disclosures related to segment reporting for public entities. It requires entities to disclose significant segment expenses for each reportable segment, providing greater transparency in segment performance. The ASU is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating how this ASU will impact its consolidated financial statements and disclosures. The Company has evaluated this ASU and there was no impact the financial statements and disclosures.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU enhances the transparency and decision usefulness of income tax disclosures. It is designed to provide more detailed information about an entity’s income tax expenses, liabilities, and deferred tax items, potentially affecting how companies report and disclose their income tax-related information. The ASU is effective for public business entities for annual periods beginning after December 15, 2024, including interim periods within those fiscal years The Company is currently evaluating how this ASU will impact its consolidated financial statements and disclosures.

~~Management~~In November ~~does~~2024, ~~not~~the ~~believe~~FASB ~~any~~issued ~~other~~ASU ~~recently~~2024-03 ~~issued~~“Disaggregation of Income Statement Expenses,” ~~but~~which ~~not~~requires ~~yet~~the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective ~~accounting~~for ~~pronouncements~~annuals ~~would~~periods ~~have~~beginning with the Company’s fiscal year 2027, and interim periods within athe ~~material~~Company’s ~~effect~~fiscal onyear ~~our~~2028, ~~present~~with orearly ~~future~~adoption ~~financial~~permitted. ~~statements~~The Company is currently evaluating the impact of this ASU on its Notes to the Financial Statements.

~~NOTE~~The 4Company –has ~~ACCOUNTS~~implemented ~~RECEIVABLE~~all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

~~Accounts~~NOTE ~~Receivable~~5 at– ~~June~~ACCOUNTS ~~30,~~RECEIVABLE ~~2024 and March 31, 2025 consists of the following:~~

			June 30, 2025				March 31, 2025
Accounts Receivable		$	696			$	640

Accounts Receivable at September 30, 2025 and March 31, 2025 consist of the following:

~~Accounts receivable~~ SCHEDULE ~~balances~~OF ~~are~~ACCOUNTS ~~primarily made up of sales through the third party vendor and paid within thirty days.~~RECEIVABLE

	September 30, 2025			March 31, 2025

Beginning	$	85,668		$	-

Add: New Balances		404,424			-

Less: Payments		(397,487	)		-

Accounts receivable	$	92,605		$	640

Less: Allowances		(32,839	)		-

Net accounts receivable	$	59,766		$	640

~~NOTE~~For 5Adapti, –accounts ~~ACCOUNTS~~receivable ~~PAYABLE~~balances ~~AND~~are ~~ACCRUED~~primarily ~~LIABILITIES~~made up of sales through the third-party vendor and paid within thirty days.

~~Accounts~~Ballengee’s ~~payable~~trade accounts receivable is primarily derived from commissions earned on marketing agreements entered into by the athletes being represented and ~~accrued~~the ~~liabilities~~commissions aton ~~June~~the current year salary that athletes earn. The allowance for credit losses for trade accounts receivable was $32,839 as of September 30, 2025. ~~and~~The ~~March~~Company 31felt that since all receivables were able to be collected in 2025, there was no need for an additional allowance in 2025 ~~consists~~but ofmaintained the ~~following:~~allowance from the prior year to be conservative.

	June 30, 2025		March 31, 2025
Accounts payable	$	166,095	$	99,952
Accrued liabilities		507,166		425,666
	$	673,261	$	525,618

~~Accrued~~NOTE ~~liabilities~~6 ~~are~~– ~~made~~PREPAID ~~up of the following as June 30, 2025 and March 31, 2025:~~ASSET

Accrued Liabilities	June 30. 2025		March 31, 2025
Management Fees	$	380,000	$	293,500
Legal Counsel		127,166		132,166
	$	507,166	$	426,566

The prepaid asset at September 30, 2025 and March 31, 2025 consists of the following:

~~The~~ SCHEDULE ~~Company~~OF ~~owes $380,000~~PREPAID ~~in management fees.~~ASSET

	September 30, 2025		March 31, 2025

Prepaid asset	$	11,432	$	-

Ballengee has a prepaid asset made up of a prepaid invoice for cleaning services as of September 30, 2025. There were no prepaid assets as of March 31, 2025.

NOTE 7 – CONTRACTS RECEIVABLE

Contracts receivable at September 30, 2025 and March 31,2025 consists of the following:

SCHEDULE OF CONTRACTS RECEIVABLE

	September 30, 2025			March 31, 2025

Beginning	$	8,517,989		$	-

Add: New Balances		2,024,510			-

Less: payments		(3,684,814	)		-

Contracts receivable	$	6,857,685		$	-

Contracts receivable - current		3,432,685			-

Contracts receivable - long term		3,425,000			-

When Ballengee negotiates athlete contracts and they are signed into effect, the Company earns revenues on all current signed contracts as agent fees are guaranteed. Performance and award bonuses are recognized in the year that the bonuses are achieved. Contracts receivable represent all signed contracts that were executed for athletes still unpaid as the fees are paid by the teams on an annual basis. Contract receivable is split between the fees to be collected in the next twelve months and long-term contract receivable for fees to be paid past twelve months. The Company does not record a reserve or allowance for bad debts as all contracts for the MLB in the minors and the major leagues are guaranteed.

NOTE 8 – EQUIPMENT

Equipment at September 30, 2025 and March 31, 2025 consists of the following:

SCHEDULE OF EQUIPMENT

	September 30, 2025			March 31, 2025

Equipment	$	12,687		$	-
Less: accumulated depreciation		(12,687	)		-
Equipment, net		-			-

NOTE 9 – RIGHT OF USE ASSET

Right of use asset as of September 30, 2025 and March 31,2025 consists of the following:

	September 30, 2025			March 31, 2025

Beginning Balance	$	1,112,763		$	-

Less: Rent Expense		(75,000	)		-

Add: Amortization of interest		4,702			-

Ending Balance	$	1,042,464		$	-

On April 20, 2019, the Company entered into an operating lease with Bacchus Capital Trading, LLC (“Bacchus”), a related party under common management, for the use of corporate office space with terms of 120 months with monthly installments of $25,000. On December 31, 2019, Bacchus assigned its rights, liabilities, and obligations as landlord to White Claw Crude (“WCC”).

The terms of the lease agreement classify the lease as an operating lease in accordance with FASB ASC 842. As such, the Company has recorded a lease obligation as well as a lease asset equal to the present value of the future cash payments. In determining the discount rate for the calculation of future cash payments, the Company used the risk-free discount rate of 1.767%, which is the rate of a United States government bond as of the commencement date of the lease and for a term comparable to the lease terms.

During the three months ended September 30, 2025 and March 31, 2025, the Company paid WCC $75,000 and zero dollars of lease payments, respectively. As of September 30, 2025 and March 31,2025, $75,000 and zero dollars of these lease payments were included in accounts payable on the accompanying balance sheets.

NOTE 10 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities at September 30, 2025 and March 31, 2025 consist of the following:

	September 30, 2025		March 31, 2025

Accounts payable	$	693,635	$	99,952

Accrued liabilities		642,176		425,666
	$	1,335,810	$	525,618

Accounts payable are made up primarily to payments due to various vendors and for rent at Ballengee. As part of the agreement, the rent owed by Ballengee will be paid in shares of Adapti’s common stock based on the current stock price.

Accrued liabilities are made up of the following as September 30, 2025 and March 31, 2025:

Accrued Liabilities	September 30, 2025		March 31, 2025

Management Fees	$	510,000	$	293,500
Legal Counsel		127,166		132,166
Other accrued liabilities		5,010		-
Accrued liabilities	$	642,176	$	425,666

The Company owes $510,000 in management fees.

The $127,166 owed to two of our attorneys that are no longer providing legal services to the Company are to be settled for common shares. The remaining legal fees will be paid in cash.

NOTE 611 – CONVERTIBLE NOTES PAYABLE

Convertible Notes payable at ~~June~~September 30, 2025 and March 31, 2025 consist of the following:

	June 30, 2025		March 31, 2025
Note 1 Convertible notes payable	$	50,000	$	50,000
Note 2 Convertible note payable	$	220,000	$	-
Total convertible notes payable		270,000		50,000
Add: accrued interest		7,967		2,745
Total convertible notes payable	$	277,967	$	52,745

Convertible Notes Payable balances was $270,000 as of June 30, 2025 (including a $20,000 financing fee) and $50,000 as of March 31, 2025 plus accrued interest of $7,967 and $2,745 for a total convertible note payable balance of $277,961 and $52,745 as of June 30, 2025 and March 31, 2025, respectively.

	September 30, 2025		March 31, 2025

Note 1 Convertible notes payable	$	50,000	$	50,000
Note 2 Convertible note payable	$	220,000	$	-
Total convertible notes payable		270,000		50,000
Add: accrued interest		14,520		2,745
Total convertible notes payable	$	284,520	$	52,745

OnConvertible Notes ~~October~~Payable ~~15,~~balances ~~2024~~were $270,000 ~~the~~as ~~Company~~of ~~entered~~September ~~into~~30, a2025 ~~convertible note~~(including ~~payable with~~ a ~~vendor~~$20,000 ~~for~~financing ~~cash~~fee) ~~advanced to the Company~~ and ~~bears a 10% interest rate. This convertible note payable represents a balance of~~ $50,000 ~~for~~as aof ~~total~~March ~~principal~~31, ~~balance~~2025 plus accrued interest of $5014,~~000~~520 and $42,~~241~~745 ~~of accrued interest~~ for a total convertible note payable balance of $54284,~~241~~520 ~~as of June 30, 2025~~ and $52,745 as of ~~March~~September 3130, 2025 ~~respectively. This note is not convertible into common shares of the Company. Please note the~~ ~~maturity~~and ~~date~~March ~~of this note was extended until October 15~~31, 2025, respectively.

On ~~April~~October 2315, ~~2025~~2024, the Company entered into a convertible note payable with a vendor for cash advanced to the Company and bears a 10% interest rate, ~~and~~which matures on the one (1) year anniversary of the issuance date. The Note also contains a ~~10%~~bridge ~~financing~~/ financing fee equal to 12% of the initial principal amount, ofwhich ~~the~~is ~~note~~payable at maturity or earlier prepayment, or payable in cash at conversion. This convertible note payable represents a balance of ~~$200,000~~ ~~plus a 10% financing fee of~~ $2050,000 for a total principal balance of $~~220~~50,000 and $35,~~726~~753 of accrued interest for a total note payable of $~~223~~55,~~726~~753 as of ~~June~~September 30, 2025 and ~~zero~~$52,745 as of March 31, 2025 respectively. ~~This note is not convertible into common shares of the Company. Please note the maturity date of this note was extended until April 23, 2026.~~

~~The notes~~This ~~convert~~note is convertible into ~~shares~~Common Stock of the Company’s ~~common stock as holders~~ at ~~maturity~~a orprice ~~after~~per ~~the~~share ~~occurrence~~ of ~~an event of default~~$3. ~~The~~08. ~~conversion~~Additionally, ~~prices of~~ the ~~notes~~Company ~~include~~may ~~the~~force conversion ~~price~~in ~~shall be~~ the ~~60%~~event ~~multiplied~~that by(i) the ~~lowest~~closing ~~trading~~ price ~~during~~of the 30 ~~trading days period ending, in holder~~Company’s Common ~~sole~~Stock ~~discretion~~is ongreater ~~each~~than ~~conversion,~~$16.00 onper ~~either~~share, (iii) the ~~last~~average ~~complete~~daily ~~trading~~volume ~~day prior~~for tosuch ~~the~~10 ~~conversion~~day ~~date~~period orexceeds ~~(ii)~~10 ~~the~~million ~~conversion date. All terms of the notes~~shares, ~~including~~and ~~but not limited to interest rate,~~(iii) ~~prepayment~~the ~~terms,~~shares ~~conversion discount or look-back period~~ will be ~~adjusted~~free ~~downward~~trading ifpursuant ~~the~~to ~~Company~~Rule ~~offers~~144 ~~more~~or ~~favorable~~registered ~~terms~~for ~~to another~~resale ~~party,~~upon ~~while~~conversion. ~~this~~During ~~note~~November is2025, in ~~effect.~~exchange ~~The~~for ~~notes may be redeemed by~~ using the ~~Company~~lender atan ~~rates~~aggregate ~~ranging~~of ~~from~~5,000 ~~105%~~shares toof ~~130%~~Common ~~depending on~~Stock, the ~~redemption~~maturity date ~~provided~~of ~~that~~this nonote ~~redemption~~was isextended ~~allowed~~until ~~after~~April ~~the~~15, ~~180th day~~2026.

12On April 23, 2025, the Company entered into a convertible note payable with a vendor for cash advanced to the Company and bears a 10% interest rate and a 10% financing fee of the principal amount of the note. This convertible note payable represents a balance of $200,000 plus a 10% financing fee of $20,000 for a total principal balance of $220,000 and $8,767 of accrued interest for a total note payable of $228,767 as of September 30, 2025 and zero as of March 31, 2025 respectively. This note is convertible into Common Stock of the Company at a price per share of $3.08. Additionally, the Company may force conversion in the event that (i) the closing price of the Company’s Common Stock is greater than $20.00 per share, (ii) the average daily volume for such 10 day period exceeds 10 million shares, and (iii) the shares will be free trading pursuant to Rule 144 or registered for resale upon conversion.

~~NOTE 7 – RELATED PARTY CONVERTIBLE NOTES PAYABLE~~ 20

~~Related~~NOTE ~~party~~12 ~~convertible~~– ~~Notes~~RELATED ~~payable~~PARTY atCONVERTIBLE ~~June~~NOTES ~~30,~~PAYABLE ~~2025 and March 31, 2025 consist of the following:~~

	June 30, 2025		March 31, 2025
Campbell Trust	$	100,000	$	100,000
Stuff International		100,000		100,000
Total related party convertible notes payable		200,000		200,000
Add: accrued interest		17,096		11,113
Total related convertible notes payable, accrued interest	$	217,096	$	211,113

Related party convertible Notes payable at September 30, 2025 and March 31, 2025 consist of the following:

As SCHEDULE ofOF ~~June~~RELATED ~~30,~~PARTY ~~2025~~CONVERTIBLE ~~and~~NOTES March 31, 2025, two notes, Stuff International and Campbell made up the related note payable balance of $217,096 and $211,113, respectively. One note is to Stuff International for $100,000 and the other from Campbell Trust for $100,000. Both notes payable bear an interest of 10% and as such have accrued interest as of June 30, 2025 and March 31, 2025 was calculated to be approximately $17,096 and $11,113, respectively. The CEO of Stuff International is also the CEO of Adapti, Inc. Please see company risk factors for further details.PAYABLE

NOTE 8 – RELATED PARTY NOTES PAYABLE

	September 30, 2025		March 31, 2025

Campbell Trust	$	250,000	$	100,000
Stuff International		100,000		100,000
Total related party convertible notes payable		350,000		200,000
Add: accrued interest		55,029		11,113
Total related convertible notes payable, accrued interest	$	405,029	$	211,113

~~Related~~On ~~party~~September ~~notes~~15, ~~payable~~2025, atin ~~June~~exchange 30for $150,000, the Company entered into a 17.5% original issue discount senior convertible promissory note for a face value of $181,818. The Note has a maturity date of December 14, 2025, and ~~March~~begins 31to accrue interest at 20% per 90 day period, ~~2025~~beginning ~~consists~~on the maturity date, if not repaid or converted into common stock of the ~~following~~Company. The conversion price per share is equal to the lesser of (i) $3.08 and (ii) 70% of the closing price of the Common Stock on the date of conversion. The note was repaid in full for $181,818 on November 5, 2025.

	June 30, 2025		March 31, 2025
Stuff International		223,246		223,246
Total Related Party Notes Payable		223,246		223,246
Accrued Interest		24,832		19,267
Related Party Notes Payable	$	248,077	$	242,511

On September 24, 2025, the Company entered into a convertible note payable with a vendor for cash advanced to the Company and bears a 10% interest rate, which matures on the one (1) year anniversary of the issuance date. This convertible note payable represents a balance of $112,197 for a total principal balance of $100,000 and $12,297 of accrued interest for a total note payable of $112,197 as of September 30, 2025 and $106,115 as of March 31, 2025 respectively. This note is convertible into Common Stock of the Company at a price per share of $3.08. Additionally, the Company may force conversion in the event that (i) the closing price of the Company’s Common Stock is greater than $16.00 per share, (ii) the average daily volume for such 10 day period exceeds 10 million shares, and (iii) the shares will be free trading pursuant to Rule 144 or registered for resale upon conversion. During November 2025, in exchange for using the lender an aggregate of 5,000 shares of Common Stock, the maturity date of this note was extended until September 25, 2026.

~~There is~~On ~~one~~October ~~remaining~~24, ~~related~~2024, ~~party~~the Company entered into a convertible note payable aswith ofa ~~June~~vendor ~~30,~~for ~~2025~~cash advanced to the Company and ~~March~~bears 31a 10% interest rate, ~~2025~~which matures on the one (1) year anniversary of the issuance date. The ~~note~~Note isalso ~~from~~contains ~~Stuff~~a ~~International~~bridge ~~and~~/ ~~totals $223,246~~financing ~~plus~~fee ~~accrued~~equal ~~interest~~to 12% of ~~$24~~the initial principal amount,~~832~~ ~~(as~~which ofis ~~June~~payable ~~30,~~at maturity ~~2025)~~or ~~and~~earlier ~~$19~~prepayment,~~267~~ ~~(as~~or ofpayable ~~March~~in ~~31,~~cash ~~2025)~~at ~~for~~conversion. This convertible note payable represents a balance of $111,014 for a total principal balance of $~~248~~100,~~077~~ 000 and $~~242~~11,~~511~~014 of accrued interest for a total note payable of $111,014 as of ~~June~~September 30, 2025 and $104,107 as of March 31, 2025, respectively.

~~There was~~This ~~another~~ note tois ~~MGI~~convertible ~~which~~into ~~was~~Common ~~settled~~Stock as of ~~March~~the Company ~~31,~~at ~~2025.~~a ~~Per~~price ~~the~~per ~~terms~~share of ~~this~~$3.08. ~~note~~Additionally, itthe ~~was~~Company ~~fully~~may ~~settled~~force ~~for~~conversion ~~common~~in ~~stock.~~the event that (i) the closing price of the Company’s ~~The~~Common ~~MGI~~Stock ~~note~~is ~~was~~greater ~~full~~than ~~converted~~$16.00 ~~for~~per 29share,~~6666~~ ~~common~~(ii) ~~stock~~the inaverage ~~total~~daily ~~settlement~~volume offor ~~note~~such ~~payable~~10 ~~balance~~day ofperiod ~~$252~~exceeds 10 million shares,~~003~~ ~~plus~~and ~~accrued~~(iii) ~~interest~~the ofshares 32will be free trading pursuant to Rule 144 or registered for resale upon conversion. During November 2025,~~795~~ in exchange for ausing the ~~total~~lender ~~balance~~an aggregate of ~~$284~~5,~~797~~000 onshares ~~March~~of 31Common Stock, ~~2025.~~the ~~This~~maturity ~~represented~~date aof ~~20%~~this ~~discounted~~note ~~share~~was ~~price~~extended atuntil ~~that~~October ~~time~~25, ~~of $9~~2025.~~60 per share.~~

As a result there is one convertible note payable to Stuff International for $100,000. There are two convertible notes payable to Campbell Trust, the first for $100,000 and the second for $150,000 mentioned above.

As of September 30, 2025 and March 31, 2025, there was a total of three convertible notes payable outstanding to Stuff International and Campbell Trust representing a total related note payable balance of $405,029 and $211,113, respectively.

The CEO of Stuff International is also the CEO of the Company, Adam Nicosia. The trustee of Campbell Trust is also the executive chairman of the Company, Jeff Campbell. Please see the section of this Form 10-Q entitled “Risk Factors” for additional information.

NOTE 13 – RELATED PARTY NOTES PAYABLE

Related party notes payable at September 30, 2025 and March 31, 2025 consists of the following

SCHEDULE OF RELATED PARTY NOTES PAYABLE

	September 30, 2025		March 31, 2025

Campbell Note Payable	$	250,000	$	-
Stuff International		223,246		223,246
Total Related Party Notes Payable		473,445		223,246

Accrued Interest		40,459		19,267

Related Party Notes Payable	$	513,704	$	242,511

On June 2, 2025, Ballengee entered into a note payable for $250,000 bearing an interest rate of 12% for 90 days. As September 30, 2025, this note had accrued interest of $10,000.

The remaining related party note payable is from Stuff International and totals $223,246 plus accrued interest of $30,459 (as of September 30, 2025) and $19,267 (as of March 31, 2025) for a total balance of $253,704 and $242,511 as of March 31, 2025, respectively. This note payable bears a 10% interest rate.

There was another note to MGI which was settled as of March 31, 2025. Per the terms of this note, it was fully settled for common stock. The MGI note was fully converted for 29,6666 common stock in total settlement of note payable balance of $252,003 plus accrued interest of 32,795 for a total balance of $284,797 on March 31, 2025. This represented a 20% discounted share price at that time of $9.60 per share.

On March 31, 2025, the balance related to Market Group International is $252,003 plus accrued interest of $32,795 for a total balance of $284,797. This entire balance was converted per the terms of the note payable agreement to common stock at a 20% discount to market. The market price at that time was $12.00 so the conversion price was $9.60 for 29,6666 common shares. As a result there was zero balance remaining owed to Market Group International as of March 31, 2025.

~~This~~Market ~~note~~Group ~~was~~International ~~convertible~~is toowned ~~common~~by ~~stock~~Robert ~~with~~Van ~~the~~Boreum ~~following~~our ~~terms:~~ex if– ~~the~~Chief ~~Filing~~Executive ofOfficer ~~the~~and ~~Form~~it 10holds ~~occurred prior to the Maturity Date~~259,412 ~~any part~~ of ~~the~~our outstanding ~~balance~~common stock ofas ~~the Note into fully paid and non-assessable shares~~ of ~~Common~~September ~~Stock at the Qualified Filing conversion Price~~30, ~~provided~~2025 ~~that in no event shall this Note be converted in excess of that portion of this Note upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder~~ and ~~its~~March ~~affiliates~~31, ~~and~~2025, (2) the number of shares of Common Stock issuable upon the conversion of the portion of this Note with respect to which the determination of this provision would result in beneficial ownership by the Holder and its affiliates of more than 4respectively.~~99% of the outstanding shares of Common Stock.~~

13The Stuff international Note payable represents a balance of $223,246 of principal and $30,459 accrued interest for a total note payable of $253,704 as of September 30, 2025. The Campbell Note payable represents a balance of $250,000 of principal and $10,000 accrued interest for a total note payable of $260,000 as of September 30, 2025. This note is not convertible into common shares of the Company. Adam Nicosia our current Chief Executive Officer owns Stuff International. He also owns Ecoscientific Labs that owns 475,000 shares of common stock as of September 30, 2025 and March 31, 2025, respectively. Please note the maturity date of this note was extended until December 31, 2025.

~~The~~NOTE ~~conversion~~14 ~~price~~– ~~upon~~COMMISSION a Filing Conversion shall equal the lower of (i) 80% of the opening price of the Borrower’s shares of Common Stock, as listed on the Senior Exchange, on the first day on which the/ Borrower’s shares are traded thereon (representing a 20% discount), or (ii) 80% of the offering price of shares of Common Stock, (representing a 20% discount) (the “Filing Conversion Price”); (B) the conversion price upon a Non-Filing Conversion shall equal 80% of the Market Price.PAYABLE

~~Market~~The ~~Group~~Company ~~International~~has isa ~~owned~~line ~~by Robert Van Boreum our ex – Chief Executive Officer and it holds 259,412~~ of ~~our~~commissions ~~outstanding~~payable ~~common stock~~at asSeptember ~~of June~~ 30, 2025 and March 31, 2025, ~~respectively.~~consisting of the following:

~~The~~ SCHEDULE ~~second~~OF ~~note~~COMMISSION ~~payable is to Stuff International for funds advanced to the Company and bears a 10% interest rate.~~PAYABLE

The Stuff international Note payable represents a balance of $232,246 of principal and $24,832 accrued interest for a total note payable of $248,077 as of June 30, 2025. The Stuff international Note payable represents a balance of $223,246 of principal and $19,267 accrued interest for a total note payable of $245,511 as of March 31, 2025. This note is not convertible into common shares of the Company. Adam Nicosia our current Chief Executive Officer owns Stuff International. He also owns Ecoscientific Labs that owns 475,000 of common stock as of June 30, 2025 and March 31, 2025, respectively. Please note the maturity date of this note was extended until December 31, 2025.

	September 30, 2025		March 31, 2025

Commissions payable	$	4,213,575	$	-
Total commissions payable	$	4,213,575	$	-

Commissions payable - current	$	2,341,989	$	-
Commissions payable – long term	$	1,871,586	$	-

~~NOTE 9 – EIDL LOAN~~ 22

~~EIDL~~Commissions ~~Loan~~payable atconsist ~~June~~of ~~30,~~the ~~2025~~entire amount of commissions earned on executed contracts in the current year for athletes to the Ballengee’s agents. All commissions are expensed and ~~March~~booked ~~31,~~as ~~2025~~a ~~consists~~payable ofin the ~~following:~~year the contract is executed and offset as it is paid when amounts due under the contract are paid to Ballengee.

	June 30, 2025		March 31, 2025
EIDL Loan	$	7,000	$	7,000
Total EIDL Loan	$	7,000	$	7,000

NOTE 15 – DUE TO RELATED PARTY

OnAmounts ~~April~~due ~~21,~~to ~~2020~~related ~~the~~parties ~~Company~~at ~~received~~September ~~an EIDL Advance of $7,000, which the Company has recorded as a loan in the event the grant is not forgiven. As of June~~ 30, 2025 and March 31, 2025 ~~the~~consist ~~balance~~ of ~~EIDL~~the ~~loans is $7,000 respectively.~~following

14 SCHEDULE OF AMOUNT DUE TO RELATED PARTIES

NOTE 10: STOCKHOLDERS’ DEFICIT

	September 30, 2025		March 31, 2025
Edgeware Energy		135,000		-
Jorgan Development, LLC	$	448,341	$	-
Total due to related party		583,024		-
Accrued Interest		-		-
Total due to related party	$	583,024	$	-

Ballengee received operating loans from Jorgan Development, LLC (“Jorgan”), a Texas limited liability company owned by James H. Ballengee (“James”), a manager of Ballengee. The loans have no stated repayment terms and are zero- interest bearing. As of September 30, 2025, Ballengee owed a total of $448,341 to Jorgan.

In addition, James H Ballengee advanced $135,000 from his other company called Edgeware Energy which is also a Texas Limited liability company also owed by James H Ballengee. The loan also has no stated repayment are zero-interest bearing. As of September 30, 2025, the Company owed a total of $135,000 to Edgeware.

NOTE 16 –LINE OF CREDIT

The Company has a line of credit balance at September 30, 2025 and March 31, 2025 consisting of the following:

SCHEDULE OF LINE OF CREDIT

	September 30, 2025		March 31, 2025

Line of credit	$	361,272	$	-
Total Line of credit	$	361,272	$	-

On March 2, 2020, Ballengee entered into a line of credit consisting of a loan and security agreement as well as an accompanying promissory note for $1,500,000, which was initially due on May 31, 2021, with an origination fee of 1.5%. Amounts underlying the line of credit were personally guaranteed by James Ballengee and the loans were further secured by all of the assets of Ballengee. The maximum loan amount was originally the lesser of (i) $1,500,000 or (ii) 70% of certain of Ballengee’s eligible accounts as described in the loan and security agreement. On May 31, 2022, the maximum loan amount was increased to $3,000,000. On April 26, 2023, Ballengee entered into an amendment to the loan documents extending the maturity date of the loan to August 31, 2023. On September 30, 2023, the maturity date of the loan was extended to September 30, 2024. On June 27, 2025, Ballengee entered into an amendment to the loan documents extending the maturity date to August 27, 2025. The loans underlying the line of credit bear an interest rate of 8.50% per annum.

On October 3, 2025, Ballengee paid off the line of credit in full for the remaining balance of $361,272, which released all personal guarantees and security interests held by the financial institution.

NOTE 17 – RELATED PARTY CONVERTIBLE NOTES PAYABLE – LONG TERM

Related party convertible Notes payable at September 30, 2025 and March 31, 2025 consist of the following:

	September 30, 2025		March 31, 2025

Stuff International	$	1,478,400	$	-
Campbell Trust		492,800		-
Brassington		184,000		-
Total related party convertible notes payable		2,156,000		-
Add: accrued interest		13,881		-
Total related convertible notes payable, accrued interest	$	2,169,881	$	-

On August 14, 2025, we issued subordinated convertible promissory notes to Brassington, our interim CFO, in the principal amount of $184,800 (“Brassington Note”), Jeff Campbell, our executive chairman, in the principal amount of $492,800 (“Campell Note”) and Adam Nicosia, our CEO, in the principal amount of $1,478,400 (the “Nicosia Note”). The Brassington Note, Campbell Note and Nicosia Note (collectively, the “Notes”) have a maturity date of three (3) years from issuance, accrue interest at the rate of 5% per annum, and are payable by the Company in full at maturity. The Notes are also convertible into Common Stock of the Company at the holder’s election at any time at a conversion price of $3.08 per share. Additionally, at maturity, the Company has the right to require holder to convert the Note(s) into shares of Common Stock at a conversion price of $3.08 per share.

As of September 30, 2025 and March 31, 2025, three long term convertibles notes, Nicosia Note, Campbell Note, and Brassington note, total $2,156,000 of principal and accrued interest $13,888, respectively. The CEO of Stuff International is also the CEO of Adapti, Inc. The Executive chairman, Jeff Campbell is also the Trustee of Campbell Trust.

NOTE 18 – RELATED PARTY NOTES PAYABLE- LONG TERM

Related party notes payable at September 30, 2025 and March 31, 2025 consist of the following

	September 30, 2025		March 31, 2025

BSG Holdings, LLC	$	7,425,000	$
JBAH Holdings, LLC		75,000		-
Total Related Party Notes Payable		7,500,000		-

Accrued Interest		80,137		-

Related Party Notes Payable	$	7,580,137	$	-

As part of the acquisition of Ballengee, the Company issued two participating promissory notes payable due June 30, 2030 with an 5% annual interest rate for $7,425,000 of principal to JBAH Holdings, LLC and the other for $75,000 to BSG Holdings, LLC. As September 30, 2025 these notes have accrued interest of $80,137 for total related party notes payable of $7,580,137.

NOTE 19 – OPERATING LEASE LIABILITY

Right of use liability at September 30, 2025 and March 31, 2025 consist of the following:

SCHEDULE OF RIGHT OF USE LIABILITY

	September 30, 2025		March 31, 2025

Operating lease liability, current	$	300,000	$	-
Operating lease liability, long term		742,464		-
Total operating lease liability	$	1,042,464	$	-

On April 20, 2019, Ballengee entered into an operating lease with Bacchus Capital Trading, LLC (“Bacchus”), a related party under common management, for the use of corporate office space with terms of 120 months with monthly installments of $25,000. On December 31, 2019, Bacchus assigned its rights, liabilities, and obligations as landlord to WCC. The Company, will continue the lease and accompanying obligations owed to WCC every month for the next twelve months. These lease payments are payable to landlord in shares at the end of each month based on the current common stock trading share price of the Company.

During the three months ended September 30, 2025 and March 31, 2025, the Company paid WCC $75,000 and zero dollar of lease payments, respectively. As of September 30, 2025 and March 31, 2025, $75,000 and zero dollars of these lease payments were included in accounts payable on the accompanying balance sheets. The Company expects to pay the monthly rent expense in common shares at market price at that time.

Operating Lease Liabilities

Future minimum lease payments for each of the next five years and beyond are as follows:


2025	$	75,000
2026		300,000
2027		300,000
2028		300,000
2029		100,000
Total minimum lease payments		1,075,000
Less: amount representing interest		(32,536	)
Total lease obligation		1,042,464
Less: current portion		(300,000	)
Total lease obligation, less current portion	$	742,464

NOTE 20 – EIDL LOAN

EIDL Loan at September 30, 2025 and March 31, 2025 consists of the following:

SCHEDULE OF EIDL LOAN

	September 30, 2025		March 31, 2025
SBA LOAN	$	80,900	$	80,900
EIDL Loan	$	7,000	$	7,000

Total EIDL Loan	$	87,900	$	87,900

On April 21, 2020, Ballengee received an EIDL Advance of $7,000, which Ballengee has recorded as a loan in the event the grant is not forgiven. As of September 30, 2025 and March 31, 2025 the balance of EIDL loans is $7,000 respectively.

Note payable to the Small Business Administration (“SBA”) dated July 17, 2020, with interest-only monthly payments of $395 at 3.75%. The principal amount of the note at issuance was $80,900. The note matures on June 15, 2050 at which time the entire principal amount plus any accrued outstanding interest is due. The long-term debt is collateralized by a security interest in all tangible and intangible property of the Company and requires communication with SBA if there are changes to the Company’s legal structure, place of business, jurisdiction of organization or name. The Company makes the standard monthly payment which is 100% interest.

On November 5, 2025, this loan has been repaid in full by Ballengee.

NOTE 21: STOCKHOLDERS’ DEFICIT

Authorized Capital Stock

The Company’s authorized capital stock consists of (a) 40,00000,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”), (b) 20,000,000 shares of Preferred Stock, $0.001 par value per share (“Preferred Stock”).

As of ~~June~~September 30, 2025 and March 31, 2025, the Company had 18,~~539~~039,259 shares and 1,532,388 shares of Common Stock and zero shares of ~~Preferred~~ Preferred Stock issued and outstanding. All outstanding shares of Common Stock are fully paid and nonassessable.

Common Stock

The Nevada Revised Statues ~~provides~~provide that the holders of the Common Stock shall have one vote per share. In addition, except as otherwise required by law, as provided in ~~this~~the Articles of Incorporation, and as otherwise provided in the resolution or resolutions, if any, adopted by the Board with respect to any series of the Preferred Stock, on any matter presented to the holders of Common Stock and Preferred Stock for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting), the holders thereof shall vote together as a single class.

Holders of the Common Stock will have no preemptive or conversion rights or other subscription rights. The Bylaws of the Company provide that the holders of Common Stock shall not have a right to cumulative voting. The rights, preferences, and privileges of the holders of the Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate and issue in the future. Additionally, the Bylaws may be amended by the Company’s stockholders or the Board of Directors.

On May 27, 2025, the Company received approval from FINRA for a number of corporate actions including a name change from Scepter Holdings, Inc. to Adapti, Inc., a 1-for-4,000 reverse stock split and a symbol change to ADTI. The name change was effective immediately, the reverse split took effect on May 28, 2025 and the symbol change took effect on June 25, 2025.

Preferred Stock

There are no shares of Preferred Stock outstanding as of ~~June~~September 30, 2025 and March 31, 2025. The Company’s Articles of Incorporation, as amended authorizes the issuance of up to 20,000,000 shares of Preferred Stock

Common Stock

No dividends, if dividends were issued holders would have a pro-rata right, 1 share 1 vote, no preemption rights.

1526

Preferred Stock

No outstanding Preferred shares.

Issuance of Common Shares

During the quarter ended September 30, 2025, the Company issued 6,500,000 restricted shares of common stock to BSG Holdings and JBAH Holdings as part of the consideration paid for the acquisitions of Ballengee Group.

Issuances of Common Stock from the Conversion of Notes

During the quarter ended March 31, 2025, the Company issued 29,500 restricted shares of common stock to MGI after reverse stock split, in full settlement of MGI note payable balance of $284,797 of which principal balance of $252,003 and $32,795 of accrued interest at 20% discount to market conversion price of $9.60.

During the quarter ended December 31, 2024, the Company issued 1,250 restricted shares of common stock to Vasil Papov, in exchange for professional services for a total value $11,500.

During the quarter ended December 31, 2024, the Company issued 7,500 restricted shares of common stock to Steven Davis in exchange for his professional services at a price of $2.80 per share for a total value of $21,000.

During the quarter ended June 30, 2024, the Company issued 10,417 restricted shares of common stock to EcoScientific Labs, in exchange for Adam Nicosia’s Management services at a price of $9.20 per share for total compensation costs of $95,833.

During the quarter ended March 31, 2024, the Company issued 625 restricted shares of common stock to Vasil Popov in exchange for his professional services.

During the quarter ended March 31, 2024, the Company issued 15,625 restricted shares of common stock to EcoScientific Labs, in exchange for Adam Nicosia’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

During the quarter ended December 31, 2023, the Company issued 625 restricted shares of common stock to Vasil Popov in exchange for his professional services at a price of $9.20 per share for total compensation costs of $5,750.

During the quarter ended December 31, 2023, the Company issued 15,625restricted shares of common stock to EcoScientific Labs, in exchange for Adam Nicosia’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

During the quarter ended December 31, 2023, the Company issued 625 restricted shares of common stock to Johannesen Consulting, Inc., in exchange for Thomas Johannesen’s professional services at a price of $9.20 per share for total compensation costs of $11,500.

During the quarter ended December 31, 2023, the Company issued 71,857 restricted shares of common stock to Johannesen Consulting, Inc., for the conversion of $287,430 of debt.

During the quarter ended December 31, 2023, the Company issued 15,625 restricted shares of common stock to Market Group International in exchange for Robert Van Boerum’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

During the quarter ended September 30, 2023, the Company issued 625 restricted shares of common stock to Vasil Popov in exchange for his professional services at a price of $9.20 per share for total compensation costs of $5,750.

During the quarter ended September 30, 2023, the Company issued 15,625 restricted shares of common stock to EcoScientific Labs, in exchange for Adam Nicosia’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

During the quarter ended September 30, 2023, the Company issued 625 restricted shares of common stock to Johannesen Consulting, Inc., in exchange for Thomas Johannesen’s professional services at a price of $9.20 per share for total compensation costs of $11,500.

During the quarter ended September 30, 2023, the Company issued 71,857 restricted shares of common stock to Johannesen Consulting, Inc., for the conversion of $287,430 of debt.

During the quarter ended September 30, 2023, the Company issued 15,625 restricted shares of common stock to Market Group International in exchange for Robert Van Boerum’s Management services.

During the quarter ended June 30, 2023, the Company issued 3,514 shares of common stock to Paul Kison for the conversion of $15,000 of debt.

During the quarter ended June 30, 2023, the Company issued 625 restricted shares of common stock to Vasil Popov in exchange for his professional services at a price of $9.20 per share for total compensation costs of $5,750.

During the quarter ended June 30, 2023, the Company issued 15,625 restricted shares of common stock to EcoScientific Labs, in exchange for Adam Nicosia’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

During the quarter ended June 30, 2023, the Company issued 625 restricted shares of common stock to Johannesen Consulting, Inc., in exchange for Thomas Johannesen’s professional services at a price of $9,.20 per share for total compensation costs of $11,500.

During the quarter ended June 30, 2023, the Company issued 15,625 restricted shares of common stock to Market Group International in exchange for Robert Van Boerum’s Management services at a price of $9.20 per share for total compensation costs of $143,750.

1728

Date of Transaction

Transaction type (e.g., new issuance, cancellation, shares returned to treasury)

Number of Shares Issued (or cancelled)

Class of Securities

Value of shares issued ($/per share) at Issuance

Were the shares issued at a discount to market price at the time of issuance? (Yes/No)

Individual/ Entity Shares were issued to. *You must disclose the control person(s) for any entities listed.

Reason for share issuance (e.g. for cash or debt conversion) -OR- Nature of Services Provided

Restricted or Unrestricted as of this filing.

3/31/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

3/31/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

3/31/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

3/31/23

New Issuance

625

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

4/5/23

New Issuance

13,514

Common

4.48

Yes

Paul Kison

Debt Conversion

Restricted

6/30/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

6/30/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

6/30/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

6/30/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

8/29/23

New Issuance

71,857

Common

4.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Debt Conversion

Restricted

9/30/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

9/30/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

9/30/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

9/30/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

10/27/23

New Issuance

3,715

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

2,754

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

3,509

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

7,643

Common

8.32

Yes

CZA, Inc.

Debt Conversion

Restricted

12/31/23

New Issuance

15,625

Common

8.32

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

12/31/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

12/31/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

12/31/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

3/31/24

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

3/31/24

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

6/30/24

New Issuance

10,417

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

12/31/24

New Issuance

7,500

Common

28.00

SD Law Group

Professional Services

Restricted

12/31/24

New Issuance

1,250

Common

9.20

Vasil Popov

Professional Services

Restricted

3/31/25

New Issuance

29,666

Common

9.60

Market Group International (Robert Van Boerum)

Note Payable

Restricted

6/30/25

Rounding Adjustment from reverse split

6,871

Common

N/A

Restricted

Shares Outstanding on Date of This Report:

Date 6/30/2025

Ending Balance Common: 1,539,259

SCHEDULE OF STOCKHOLDERS EQUITY

Date of Transaction

Transaction type (e.g., new issuance, cancellation, shares returned to treasury)

Number of Shares Issued (or cancelled)

Class of Securities

Value of shares issued ($/per share) at Issuance

Were the shares issued at a discount to market price at the time of issuance? (Yes/No)

Individual/ Entity Shares were issued to. *You must disclose the control person(s) for any entities listed.

Reason for share issuance (e.g. for cash or debt conversion) -OR- Nature of Services Provided

Restricted or Unrestricted as of this filing.

3/31/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

3/31/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

3/31/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

3/31/23

New Issuance

625

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

4/5/23

New Issuance

13,514

Common

4.48

Yes

Paul Kison

Debt Conversion

Restricted

6/30/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

6/30/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

6/30/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

6/30/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

8/29/23

New Issuance

71,857

Common

4.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Debt Conversion

Restricted

9/30/23

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

9/30/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

9/30/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

9/30/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

10/27/23

New Issuance

3,715

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

2,754

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

3,509

Common

8.32

Yes

OC Sparkle

Debt Conversion

Restricted

10/27/23

New Issuance

7,643

Common

8.32

Yes

CZA, Inc.

Debt Conversion

Restricted

12/31/23

New Issuance

15,625

Common

8.32

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

12/31/23

New Issuance

15,625

Common

8.00

Market Group International (Robert Van Boerum)

Professional Services

Restricted

12/31/23

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

12/31/23

New Issuance

1,250

Common

8.00

Johannesen Consulting, Inc. (Thomas Johannesen)

Professional Services

Restricted

3/31/24

New Issuance

15,625

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

3/31/24

New Issuance

625

Common

8.00

Vasil Popov

Professional Services

Restricted

6/30/24

New Issuance

10,417

Common

8.00

EcoScientific Labs (Adam Nicosia)

Professional Services

Restricted

12/31/24

New Issuance

7,500

Common

28.00

SD Law Group

Professional Services

Restricted

12/31/24

New Issuance

1,250

Common

9.20

Vasil Popov

Professional Services

Restricted

3/31/25

New Issuance

29,666

Common

9.60

Market Group International (Robert Van Boerum)

Note Payable

Restricted

6/30/25

Rounding Adjustment
from reverse split

6,871

Common

N/A

Restricted

7/1/2025

New Issuance

65,000

Common

3.076

JBAH
HOLDINGS, LLC

Ballengee Group Acquisitions

Restricted

7/14/2025

New Issuance

6,435,000

Common

3.076

BSG HOLDINGS, LLC

Ballengee Group Acquisitions

Restricted

Shares Outstanding on Date of This Report:

Date 9/30/2025

Ending Balance
Common: 8,039,259

~~NOTE 11 – COMMITMENTS~~29

NOTE 22 – COMMITMENTS

Lease Commitments

The Company determines if an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys to the Company the right to control the use of an explicitly or implicitly identified fixed asset for a period of time in exchange for consideration. Control of an underlying asset is conveyed to the Company if the Company obtains the rights to direct the use of and to obtain substantially all of the economic benefits from using the underlying asset. The Company has lease agreements which include lease and non-lease components, which the Company has elected to account for as a single lease component for all classes of underlying assets. Lease expense for variable lease components are recognized when the obligation is probable.

Operating lease right of use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease payments are recognized as lease expense on a straight-line basis over the lease term. The Company primarily leases buildings (real estate) which are classified as operating leases. ASC 842 requires a lessee to discount its unpaid lease payments using the interest rate implicit in the lease or, if that rate cannot be readily determined, its incremental borrowing rate. As an implicit interest rate is not readily determinable in the Company’s leases, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments.

The lease term for all of the Company’s leases includes the non-cancellable period of the lease plus any additional periods covered by either a Company option to extend (or not to terminate) the lease that the Company is reasonably certain to exercise, or an option to extend (or not to terminate) the lease controlled by the lessor. Options for lease renewals have been excluded from the lease term (and lease liability) for the majority of the Company’s leases as the reasonably certain threshold is not met.

Lease payments included in the measurement of the lease liability are comprised of fixed payments, variable payments that depend on index or rate, and amounts probable to be payable under the exercise of the Company option to purchase the underlying asset if reasonably certain.

Variable lease payments not dependent on a rate or index associated with the Company’s leases are recognized when the event, activity, or circumstance in the lease agreement on which those payments are assessed as probable. Variable lease payments are presented as operating expenses in the Company’s income statement in the same line item as expense arising from fixed lease payments. As of ~~June~~ September 30, 2025 and March 31, 2025, management determined that there were no variable lease costs.

Litigation

~~There~~Except for routine litigation, there is no pending, threatened or actual legal proceedings in which the Company is a party.

NOTE 1223: SUBSEQUENT EVENTS

~~Acquisition~~On October 3, 2025, the Company paid off the line of credit in full for the remaining balance of $361,272 of a secured line of credit entered into by Ballengee, ~~Group~~which released all personal guarantees and security interests held by the financial institution.

On ~~July~~October 1417, 2025, ~~we closed~~ the ~~acquisition~~Company ofentered ~~100%~~into ofa ~~the~~settlement ~~membership~~agreement ~~interests~~with ofa ~~The~~former Ballengee ~~Group,~~agent. ~~LLC,~~There ~~(“Ballengee”) a~~will ~~Dallas-based~~be ~~baseball~~no ~~sports~~impact ~~management agency which represents approximately 200 professional athletes. Pursuant~~ to the ~~acquisition,~~contracts ~~the~~already ~~security~~recognized ~~holders~~until ofSeptember ~~Ballengee received: (i) 6~~30,~~500,000~~ ~~shares~~2025. ofThe ~~our~~Company ~~Common~~is ~~Stock,~~to ~~(ii)~~pay aout ~~participating~~commissions ~~promissory note in the aggregate principal amount of $7,500,000, and (iii) the right~~ to ~~contingent~~this ~~earnout~~former ~~consideration~~agent ofas upagreed toin ~~$20,000,000,~~the ~~payable~~settlement ~~in shares of Adapti Common Stock~~agreement. The ~~Company~~Commissions ~~disclosed~~are ~~the~~fully ~~completion of the acquisition on a Current Report on Form 8-K on July 18, 2025 (see Form 8-K filing for more information)~~accrued.

~~Contemporaneously~~On November ~~with~~6, ~~the~~2025, ~~acquisition~~Ballengee entered into a revolving line of credit for up to $3,000,000 (“Revolving Loan”) with Texas Security Bank. Additionally, 2278 Monitor, LLC (“2278”), an entity controlled by James Ballengee, ~~Jeff~~our ~~Campbell~~majority ~~was~~shareholder, entered ~~appointed~~into a revolving line of credit for up to ~~the~~$2,000,000, ~~position~~secured by 2278’s real property holdings. As of ~~Executive~~November ~~Chairman~~14, 2025, no dollars has been drawn down off of ~~our~~the ~~Board~~Revolving Loan by Ballengee. All amounts due under the Revolving Loan are secured by substantially all of ~~Directors~~the assets of Ballengee. Additionally, Ballengee entered into a cross collateralization agreement whereby any default under loans entered into by 2278, by real property will result in a default under the Revolving Loan.

~~Employment~~During ~~Agreement~~November ~~and~~2025, ~~Related~~the ~~Contracts~~Company ~~with~~agreed ~~Marilu~~to ~~Brassington~~extend the maturity dates of the following loans:

On● ~~August~~The 14maturity date of a convertible promissory note entered into on October 10, ~~2025~~2024 that matured 12 months thereafter, wewas extended until April 10, 2026 in exchange for the Company issuing the lender 5,000 shares of Common Stock. ● The maturity date of a convertible promissory note entered into on October 30, 2024 by the Company and Stuff International, an ~~employment~~entity ~~agreement~~controlled ~~with~~by ~~Marilu Brassington~~Adam Nicosia, our ~~current~~CEO, ~~Chief~~that ~~Financial~~matured ~~Officer~~12 ~~(the~~months ~~“Brassington~~thereafter, ~~Employment~~was ~~Agreement”).~~extended ~~Pursuant~~until toOctober 30, 2026 in exchange for the ~~Brassington~~Company ~~Employment Agreement~~issuing the lender 10,000 Msshares of Common Stock. ~~Brassington~~● ~~will~~The ~~serve~~maturity asdate of a convertible promissory note entered into on September 24, 2024 by the Company’s ~~chief~~and ~~accounting~~The ~~officer~~Campbell ~~and~~Trust, ~~continue~~whereby toJeff ~~serve~~Campbell, our executive chairman, serves as ~~interim~~trustee, ~~chief~~that ~~financial officer~~matured 12 months thereafter, was extended until September 24, 2026 in exchange for the Company issuing the lender 10,000 shares of Common Stock.

~~Pursuant~~On November to5, 2025, the ~~Brassington~~Company ~~Employment~~issued ~~Agreement,~~a ~~Ms.~~consultant ~~Brassington~~a ~~receives an~~warrant ~~annual~~to ~~base~~purchase ~~salary~~up ofto ~~$180~~8,000. Onshares ~~each~~of ~~monthly~~Common ~~anniversary~~Stock ofat ~~the~~a ~~Brassington~~price ~~Employment~~per ~~Agreement~~share of $3.08, and a term of five (5) years. Of the ~~Company~~shares ~~will~~underlying ~~pay~~the ~~half~~warrant, of2,666 ~~her monthly~~vest ~~base~~immediately, ~~salary~~and 5,334 vest in ~~Common~~eight ~~Stock,~~(8) ~~valued~~equal atquarterly periods beginning on the ~~closing~~one ~~price~~(1) year anniversary of the ~~Comon~~issuance ~~Stock~~date and ending on ~~such~~the ~~applicable~~three (3) year anniversary of the issuance date.

~~We also issued Ms. Brassington a non-qualified stock option grant to purchase~~On upNovember to5, ~~120~~2025,~~000~~ ~~shares~~this ofBallengee ~~Common~~has ~~Stock~~been atrepaid ain ~~price~~full ~~per~~its ~~share~~line of $3credit.08 ~~(the~~There ~~“Option”).~~is ~~The Option was issued on August 14, 2025,~~zero ~~has~~outstanding abalance ~~term~~as of 10November ~~years from issuance~~5, ~~and vests in four (4) equal annual installments over a four (4) year period, with such first vesting event occurring on the one (1) year anniversary of the grant date~~2025.

~~Subordinated Convertible Promissory Notes Issued to Marilu Brassington, Jeff Campbell and Adam Nicosia~~30

On August 14, 2025, we issued subordinated convertible promissory notes to Marilu Brassington, our interim CFO, in the principal amount of $184,800 (“Brassington Note”), Jeff Campbell, our executive chairman, in the principal amount of $492,800 (“Campell Note”) and Adam Nicosia, our CEO, in the principal amount of $1,478,400 (the “Nicosia Note”). The Brassington Note, Campbell Note and Nicosia Note (collectively, the “Notes”) have a maturity date of three (3) years from issuance, accrue interest at the rate of 5% per annum, and are payable by the Company in full at maturity. The Notes are also convertible into Common Stock of the Company at the holder’s election at any time at a conversion price of $3.08 per share. Additionally, at maturity, the Company has the right to require holder to convert the Note(s) into shares of Common Stock at a conversion price of $3.08 per share.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and the related notes included elsewhere herein. Our historical results do not necessarily reflect what our historical financial position and results of operations would have been had we been a stand-alone public company during the years presented. In addition, our historical results are not necessarily indicative of the results to be expected for any future period, and results for any interim period are not necessarily indicative of the results to be expected for the full year. We recommend investors read this entire Quarterly Report on Form 10-Q, including the “Risk Factors” Section, the consolidated financial statements, and related notes thereto. As used in this offering, unless the context otherwise requires or indicates, “Adapti,” “Company,” “we,” “us,” and “our” or similar designations refer to Adapti, Inc., a Nevada corporation. ~~Any~~corporation ~~reference~~and toas ~~Ballengee~~applicable, orour ~~Ballengee~~wholly ~~Group~~owned ~~refers~~subsidiary, to Ballengee Group, LLC, ~~our recently acquired subsidiary,~~ (which ~~closed~~is onalso ~~July~~referred ~~14,~~to ~~2025~~as “Ballengee”).

Statements in this Quarterly Report on Form 10-Q that are not strictly historical are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. You can identify these forward-looking statements because they involve our expectations, intentions, beliefs, plans, projections, anticipations, or other characterizations of future events or circumstances. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements as a result of any number of factors. Some of these factors are more fully discussed in the section of this Quarterly Report on Form 10-Q entitled “Risk Factors” and elsewhere herein. We do not undertake to update any of these forward-looking statements or announce the results of any revisions to these forward-looking statements except as required by law.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided, in addition to the accompanying condensed consolidated financial statements and notes, to assist you in understanding our results of operations, financial condition and cash flows. The MD&A is organized as follows:

● Overview — Discussion of our business and overall analysis of financial and other items affecting our Company in order to provide context for the remainder of MD&A.

● Results of Operations — Analysis of our financial results comparing the three months ended ~~June~~September 30, 2025 and 2024.

● Liquidity and Capital Resources — An analysis of cash flows and discussion of our financial condition and future liquidity needs.

Overview

Adapti, Inc (fka Scepter Holdings, Inc.). (the “Company”) was incorporated under the laws of the State of Nevada on January 11, 2007. After ~~The~~undergoing several name changes, the Company ~~previously~~changed ~~managed~~its ~~sales~~name ~~and~~to ~~brand~~Adapti, ~~development~~Inc. ~~of health~~on ~~and~~April ~~beauty~~15, ~~products~~2025, ~~through~~to reflect a ~~product~~strategic ~~line~~shift ~~called~~in focus ~~Dermacia.~~away ~~For~~from ~~the~~health ~~period~~and ~~ended~~beauty ~~June~~product ~~30,~~sales ~~2025~~ and ~~June~~toward ~~30,~~a ~~2024,~~technology-driven ~~the~~acquisition ~~Company~~strategy ~~only~~consisting of companies operating ~~generated~~in ~~revenues~~the ofsports $4management,~~894~~ ~~and~~sports ~~$13~~marketing,~~672,~~ ~~respectively~~and athlete representation industries.

The Company ~~changed~~previously ~~its~~began ~~name~~developing toan ~~Adapti,~~AI-driven ~~Inc~~platform for sue in the beauty and health industry. onSubsequent ~~April~~to 15its acquisition of Ballengee Group, LLC (“Ballengee”) in July 2025, tothe ~~reflect~~Company ashifted ~~strategic~~its ~~shift in~~ focus ~~away~~to ~~from~~on: ~~health~~(i) acquiring and ~~beauty~~operating agencies ~~product~~that ~~sales~~manage ~~and~~athletes, ~~toward~~brands, aand ~~technology~~sports-~~driven~~related ~~acquisition~~talent ~~strategy~~and ~~consisting~~(ii) ofcontinuing ~~companies~~the ~~operating in~~development of the ~~sports~~Company’s proprietary ~~management~~AI-driven influencer and ~~sports~~brand ~~marketing~~optimization ~~industries~~platform, called AdaptAI.

The Company’s wholly owned subsidiary, Ballengee, is ~~now~~a ~~focused~~Texas-based Major League Baseball agency with approximately 200 professional ~~on:~~clients, with more than 40 in the Major Leagues. Ballengee currently have seven (i7) ~~acquiring~~full time agents and ~~operating~~a ~~agencies~~recruiting ~~that~~department. ~~manage~~Ballengee primarily ~~athletes,~~markets ~~brands,~~through ~~and~~a ~~sports~~boots-~~related~~on-ground ~~talent~~model, with a team of five scouts covering the high school and ~~(ii)~~collegiate ~~completing~~athlete markets across the ~~development~~southern ofUnited ~~adapt~~States and Sunbelt region.io The Company believes that AdaptAI, if and when completed, would assist the Company’s ~~proprietary~~in ~~AI-driven~~attempting ~~influencer~~to consolidate and ~~brand optimization~~scale ~~platform~~athlete representation and social monetization services.

InThe Company’s ~~July~~technology ~~2025~~platform, ~~the~~AdaptAI, ~~Company~~is ~~completed~~a ~~the~~proprietary ~~acquisition~~AI-driven tool being developed to identify optimal alignment ofbetween brands and social media influencers. The ~~Ballengee~~platform, ~~Group~~if and when completed, will create a ~~Texas-based~~data ~~Major~~fingerprint ~~League~~for ~~Baseball~~each ~~agency~~athlete ~~with~~or brand, ~~approximately~~enabling ~~200~~precise ~~professional~~matching ~~clients,~~with influencers whose audience and ~~more~~engagement ~~than~~metrics 40are inbest ~~the Major~~suited ~~League~~for targeted marketing campaigns. ~~Ballengee~~AdaptAI ~~primarily~~is ~~markets~~being ~~through~~designed ato ~~boots-on-ground~~continually ~~model,~~analyze proprietary data for each specific campaign along with apublic data ~~team~~sources ofas ~~five~~additional ~~scouts~~feedback ~~covering~~to ~~the~~inform ~~high~~ongoing ~~school~~promotions and ~~collegiate~~to further refine its algorithm and attempt to monetize ~~athlete~~accumulated ~~markets~~data. ~~across~~This ~~the~~strategic ~~southern~~alignment ~~United~~is ~~States~~intended to maximize exposure and ~~Sunbelt~~sponsorship ~~region~~value for its influencer and athlete clients, while maximizing response rates for partner brands. ~~The~~As ~~acquisition~~of ~~represents~~November a10, ~~material~~2025, ~~step~~AdaptAI is currently in its beta phase. Subject to the Company’s raising sufficient capital or having adequate free cash flow to cover development costs, which management ~~strategy~~estimates such development costs to ~~consolidate~~be ~~and~~approximately ~~scale~~$250,000, ~~athlete~~management ~~representation~~believes ~~and~~that ~~social~~AdaptAI ~~monetization~~will ~~services~~be completed for the Company’s internal use by December 31, 2026.

~~The Company’s~~While ~~technology~~AdaptAI ~~platform,~~development ~~adapt.io,~~currently isfocuses aexclusively ~~proprietary~~on ~~AI-driven~~brand ~~tool designed to identify optimal alignment between brands~~ and ~~social~~ ~~media~~influencer ~~influencers.~~matching, ~~The~~the ~~platform~~Company ~~creates~~has afuture ~~data~~plans ~~fingerprint~~to ~~for~~enhance ~~each athlete or brand, enabling precise matching with~~its ~~influencers~~service ~~whose~~offering ~~audience~~by ~~and~~integrating ~~engagement~~generative ~~metrics~~AI ~~are~~capabilities. ~~best~~These ~~suited~~enhancements ~~for~~will ~~targeted~~support ~~marketing~~automated ~~campaigns.~~content ~~Adapt.io~~creation isand ~~designed~~enable end-to-end ~~continually~~generative ~~analyze~~content ~~proprietary~~workflows ~~data~~ for ~~each~~social ~~specific~~media ~~campaign~~publishing ~~along with public data sources as additional feedback to inform ongoing promotions~~ and tocampaign ~~further~~execution. ~~refine~~These ~~its~~future ~~algorithm~~capabilities ~~and~~are ~~attempt~~expected to ~~monetize accumulated data. This strategic alignment is~~streamline ~~intended~~the toproduction ~~maximize exposure~~ and ~~sponsorship~~distribution ~~value~~of ~~for~~high-performing ~~its~~digital ~~influencer~~content ~~and~~across ~~athlete~~client ~~clients, while maximizing response rates for partner brands~~campaigns.

~~While~~As a ~~adapt.io~~result ~~currently~~of ~~focuses~~our ~~exclusively on~~acquisition ~~brand~~of Ballengee and ~~influencer~~continued ~~matching~~development of AdaptAI, ~~the~~The Company ~~plans~~is ceasing its efforts to ~~enhance~~market or ~~its~~sell ~~service~~health ~~offering~~and bybeauty ~~integrating~~products, ~~generative~~including AIthe ~~capabilities~~Dermacia brand. ~~These~~The ~~enhancements will~~Company ~~support~~is ~~automated~~currently ~~content~~in ~~creation~~the ~~and~~process ~~enable~~of ~~end-to-end~~selling ~~generative~~retained ~~content~~inventory, but ~~workflows~~does ~~for~~not ~~social~~plan ~~media~~on ~~publishing~~generating ~~and~~any ~~campaign~~significant ~~execution. These~~revenues in the future ~~capabilities~~from those lines. Future revenues are expected to ~~streamline~~be ~~the~~derived ~~production~~primarily from athlete representation fees, sponsorships, and ~~distribution~~once ofcompleted ~~high-performing~~and ~~digital~~tested, ~~content~~our ~~across~~AdaptAI ~~client campaigns~~platform-enabled brand integrations.

~~The~~On October 20, 2025, the Company announced that it has ~~ceased~~entered ~~its~~into ~~efforts~~a toletter ~~market~~of orintent ~~sell health~~to ~~and~~acquire ~~beauty~~Levelution ~~products~~Sports, ~~including~~a ~~the~~company ~~Dermacia~~that ~~brand~~represents NIL athletes, ~~and~~along ~~will~~with noproviding ~~longer~~compliance, ~~generating~~brand ~~revenue~~partnerships, ~~from~~and ~~those~~athlete ~~lines~~development services. ~~Future~~The ~~revenues~~Company ~~are expected~~is working to becomplete the ~~derived~~acquisition, ~~primarily~~subject ~~from~~to ~~athlete~~the ~~representation~~completion ~~fees,~~of ~~sponsorships,~~due diligence and ~~platform-enabled~~entering ~~brand~~into ~~integrations~~definitive documents.

20The Company is additionally undertaking a process to identify potential acquisitions that would provide benefit to the Company’s current business plan.

Reverse Stock Split

Effective May 28, 2025, we effected a 1-for-4,000 reverse stock split of our issued and outstanding common stock (the “Reverse Stock Split”). As a result of the Reverse Stock Split, our stockholders received one share of our common stock for every 4,000 shares each stockholder held immediately prior to the effective time of the Reverse Stock Split. Unless otherwise noted, all references to common stock shares, common stock per share data and shares of common stock underlying convertible instruments included in this Quarterly Report on Form 10-Q, including the exercise or conversion price of such equity instruments, as applicable, have been retrospectively adjusted to reflect the Reverse Stock Split.

~~Three~~Six Months Ended ~~June~~September 30, 2025 and 2024

Results of Operations

Revenues

~~Merchandise~~Revenues are primarily from revenues ~~include~~recognized on MLB contracts for its represented athletes. The Company earns a commission on all salaries, incentives, and bonuses stipulated in the contract on those bonuses when the performance targets are achieved or they are awarded as the payments for those bonuses are guaranteed by the club and approved contractually by the payments received for products shipped and sold through our vendors. Revenues for the ~~three~~six months ended ~~June~~September 30, 2025 ~~decreased~~ increased to $~~284~~2,129,123, or 30 71,499%, as compared to the ~~three~~six months ended ~~June~~September 30, 2024, primarily due ~~decreased~~revenues ~~marketing~~earned ~~efforts~~through inthe ~~2025.~~acquisitions ~~Although~~of ~~our efforts in 2024 were nominal as well~~Ballengee.

Cost of Revenues

Cost of revenues primarily ~~include~~Commissions earned on executed contracts in the ~~costs~~current ofyear ~~products~~for the athletes to the Company’s agents. All commissions are expensed and booked as a payable in the year the contract is executed and offset as it is paid when amounts due under the contract are paid to the Company. Cost of revenues for the ~~three~~six months ended ~~June~~September 30, 2025 were ~~consistently~~$1,333,525 and zero ~~compared~~for to the ~~three~~six months ended ~~June~~September 30, 2024, ~~due~~as to the ~~write~~acquisition ~~off~~ of ~~inventory~~Ballengee todid ~~zero~~not ~~during~~occur ~~the~~until ~~2024~~July ~~fiscal year~~2025.

General and administrative expenses

General and administrative expense include the costs associated with personnel to manage the sports agency. General and administrative expenses increased for the ~~three~~six months ended ~~June~~September 30, 2025 by $1587,~~161~~514, or 31,164%, as compared to the ~~three~~six months ended ~~June~~September 30, ~~2024~~2025, primarily due to the ~~increase~~acquisitions inof ~~personnel~~ Ballengee Group during ~~2025~~the ~~fiscal~~quarter ~~year~~ended September 30, 2025.

Professional fees

Professional fees include the costs ~~associated~~ with ~~outside~~professional consultants to help manage the public entity ~~as well as other professional consultants~~. Professional fees increased for the ~~three~~ six months ended ~~June~~September 30, 2025 by 72,~~739~~488,870 or 3686%, as compared to the ~~three~~six months ended ~~June~~September 30, ~~2024~~ 2025, primarily due to increased consultants ~~during~~compensation ~~2025~~to ~~fiscal~~assist ~~year~~in the acquisition of Ballengee.

Other expense

Other expense includes interest expense on note payables and on Ballengee’s secured line of credit. Other expense increased for the six ~~three~~ months ended ~~June~~September 30, 2025 by $7179,~~048~~721, or 72 879%, as compared to the ~~three~~six months ended ~~June~~September 30, 2024, primarily due to the issuance ~~fact~~of ~~that the Company issued~~ promissory notes bearing interest in 2025, ~~compared~~that towere not outstanding for the six months ended September 30, 2024.

Liquidity and Capital Resources

Our cash flow activities were as follows for the periods presented:

	Three Months Ended June 30,
	Six Months Ended September 30,
	2025			2024		Change
Net cash flows used for operating activities	$	(~~110~~603,~~709~~450	)	$	~~176~~167,970	$	~~110~~(435,~~885~~480	)
Net cash flows used for investing activities		-257,000			-		-257,000
Net cash flows provided by financing activities		~~200~~1,~~000~~886,289			-203,431		~~(200~~1,~~000~~682,858	)

Operating activities

Net cash flows used for operating activities was ($~~110~~603,~~709~~450) and $~~176~~167,970 for the ~~three~~six months ended ~~June~~September 30, 2025 and ~~2025~~2024, respectively. The decrease of net cash flows used for operating activities of $~~110~~435,~~885~~480 was primarily due to the Company ~~had~~increase ~~increased~~in commissions ~~accrued~~payable ~~expenses~~ related to ~~management~~contracts ~~fees~~entered ~~related~~into toby ~~Officers~~the ~~and consultants~~Ballengee.

Investing activities

~~There~~Net ~~were~~cash noflows used for investing activities ~~for~~is primarily made up of the ~~three~~assets acquired in the Ballengee group acquisition for the six months ended ~~June~~September 30, 2025. ~~and~~There ~~2024~~were no investing activities for the six months ended September 30, 2024, respectively.

Financing activities

~~The~~Net ~~Company~~cash ~~raised~~flows ~~$200,000~~ from financing activities is primarily made up of the ~~issuance~~purchase price paid for the acquisition of aBallengee ~~promissory~~Group. ~~note~~In additional the company issued convertible notes during the ~~three~~six months ended ~~June~~September 30, 2025. ~~compared~~There towere ~~zero~~no ~~for~~ financing activities by the ~~three~~Company for ~~months~~the ~~ended~~comparable ~~June~~period ~~30,~~in 2024.

2232

June 30, 2025

March 31, 2025

Change

September 30, 2025

March 31, 2025

Change

Cash

891,~~863~~540,411

572

891,~~291~~539,839

Current liabilities

16,~~416~~125,~~400~~348

1,031,987

~~384~~4,~~413~~985,025

The Company’s primary sources of liquidity are from ~~financing~~cash ~~activities~~flows generated from operations and to a lesser ~~extent~~extend ~~cash flows generated from operations~~financing activities. As of ~~June~~September 30, 2025 and March 31, 2025, the Company had cash of $891,~~863~~540,411 and $572, respectively. The increase in cash as of September 30, 2025 is due to cash received from contracts entered into by Ballengee. As of ~~June~~September 30, 2025 and March 31, 2025, the Company had current liabilities of $16,~~416~~125,~~400~~348 and $1,031,987, respectively.

The Company believes its existing cash and expected cash flows from operations will not be sufficient to meet our working capital, capital expenditures, and expected cash requirements from known contractual obligations for the next twelve months and beyond. It will need to raise additional capital to continue operations.

Net Loss

As a result of the foregoing, for the ~~three~~six months ended ~~June~~September 30, 2025, we incurred of a net loss of $~~295~~2,~~065~~741,382 compared to a comprehensive net loss of $~~278~~430,~~833~~875 for the ~~three~~six months ended ~~June~~September 30, 2024. The increase in net loss is primarily the result of increased professional fees.

The Company is expending working capital to further their business plan.

Three Months Ended September 30, 2025 and 2024

Results of Operations

Revenues

Revenues are primarily from revenues recognized on MLB contracts for its represented athletes. The Company earns a commission on all salaries, incentives, and bonuses stipulated in the contract on those bonuses when the performance targets are achieved or they are awarded as the payments for those bonuses are guaranteed by the club and approved contractually by the payments received for products shipped and sold through our vendors. Revenues for the three months ended September 30, 2025 increased $2,129,407, or 104,906%, as compared to the three months ended September30, 2024, primarily due revenues earned through the acquisitions of Ballengee.

Cost of Revenues

Cost of revenues primarily Commissions earned on executed contracts in the current year for the athletes to the Company’s agents. All commissions are expensed and booked as a payable in the year the contract is executed and offset as it is paid when amounts due under the contract are paid to the Company. Cost of revenues for the three months ended September 30, 2025 were $1,333,525 consistently zero compared to the three months ended September 30, 2024, due to the acquisition of Ballengee Group.

General and administrative expenses

General and administrative expense include the costs associated with personnel to manage the sports agency. General and administrative expenses increased for the three months ended September 30, 2025 by $586,354, or 13357%, as compared to the three months ended September 30, 2024, primarily due to the acquisitions of Ballengee Group during the quarter ended September 30, 2025.

Professional fees

Professional fees include the costs with professional consultants to help manage the public entity. Professional fees increased for the three months ended September 30, 2025 by 2,481,131 or 1786%, as compared to the three months ended September 30, 2025, primarily due to increased consultant compensation to assist in the acquisition of Ballengee.

Other expense

Other expense includes interest expense on note payables and on Ballengee’s secured line of credit. Other expense increased for the three months ended September 30, 2025 by $172,673, or 1610%, as compared to the three months ended September 30, 2025, primarily due to the issuance of promissory notes bearing interest in 2025 that are not outstanding for the three months ended September 30, 2024.

Net Loss

As a result of the foregoing, for the three months ended September 30, 2025, we incurred a net loss of $2,596,318 compared to a comprehensive net loss of $152,042 for the three months ended September 30, 2024. The increase in net loss is primarily the result of increased professional fees.

The Company is expending working capital to further their business plan.

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. The SEC has defined a company’s critical accounting policies as the ones that are most important to the portrayal of a company’s financial condition and results of operations, and which require a company to make its most difficult and subjective judgments. Based on this definition, the Company has identified the critical accounting policies and judgments addressed below. Estimates are based on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Recently Issued Accounting Standards

The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position, or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its consolidated financial statements. See Note 3 to the consolidated statements in this Annual Report for a complete discussion of our significant accounting policies and estimates

Other Estimates

See Note 1 to the accompanying condensed consolidated financial statements included herein and starting on page F-1 for further discussion.

Off-Balance Sheet Arrangements

As of ~~June~~September 30, 2025 and March 31, 2025, the Company had no off-balance sheet arrangements that have, or are reasonably likely to have, a a current or future effect on the Company’s financial condition, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Recently Issued and Adopted Accounting Pronouncements

See Note 1 to the accompanying audited financial statements included herein and starting on page F-1 for further discussion.

Future Liquidity Needs

The Company has met its current capital requirements primarily through the issuance of its debt securities. Management views the working capital that is raised in its promissory notes as being equivalent to raising working capital via common equity subscriptions. Certain of our promissory notes / debt securities have conversion features whereby the holder can convert the principal and accrued interest into shares of our common stock. Any conversion of debt into equity could occur at a higher equity valuation than the Company currently has.

Going Concern

The Company’s financial statements are prepared using GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. Since the Company has not generated significant revenue or gross profits adequate to cover operating costs, has negative cash flows from operations, and negative working capital, the Company has included a reference to the substantial doubt about our ability to continue as a going concern in connection with our condensed financial statements for the period ended ~~June~~September 30, 2025. Our total accumulated deficit as of ~~June~~September 30, 2025 was approximately $1016 million.

The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales notes payable. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, reduce the scope of or eliminate one or more of the Company’s research and development activities or commercialization efforts or perhaps even cease the operation of its business. The ability of the Company to continue as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying condensed financial statements. The accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United ~~States~~ States requires us to make estimates and judgments that affect our reported assets, liabilities, and expenses and the disclosure of ~~contingent~~ contingent assets and liabilities. We use assumptions that we believe to be reasonable under the circumstances. Future events, however, may differ markedly from our current expectations and assumptions. We believe there have been no significant changes in accounting policies for the period ended ~~June~~September 30, 2025. See Note 3 to the statements in this Quarterly Report for a complete discussion of our significant accounting policies and estimates.

Recently Issued Accounting Standards

The Company has reviewed all recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its condensed results of operation, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its consolidated financial statements. See Note 3 to the statements in our 2025 Annual Report for a complete discussion of our significant accounting policies and estimates.

Off-Balance Sheet Transactions

At ~~June~~September 30, 2025, the Company did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

We are not required to provide the information required by this item as we are considered a smaller reporting company, as defined by Rule 229.10(f)(1).

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our Management, with the participation of our Chief Executive Officer and interim Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures, as of ~~June~~September 30, 2025 were not effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure. A control system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Management’s Quarterly Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended ~~June~~ September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2436

PART II

OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors

Investing in our securities involves a high degree of risk. Before investing in our securities, you should carefully consider the risks and uncertainties discussed under “Risk Factors” in our latest annual report on Form 10-K and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. Before making an investment decision, you should carefully consider each of the following risks described below, together with all other information set forth in or incorporated in this Quarterly Report on Form 10-Q, including the condensed consolidated financial statements and the related notes. The risks described in this Quarterly Report on Form 10-Q are not the only ones we face, but those that we consider to be material. Additional risks not presently known to us or that we currently believe are immaterial may also significantly impair our business operations and could result in a complete loss of your investment. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of the following risks actually occur, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the market price of our common stock to decline, and you could lose all or part of your investment.

Risks Related to our Operating History; Integration of Acquired Businesses; and Business Plan

We have a limited operating history and recently changed our business plan, which makes it difficult to evaluate our future prospects and increases the risk of your investment.

We are an early-stage company with a limited operating history, and our historical financial results provide little basis to evaluate our current or future business prospects. Until recently, our primary focus was on consumer products, but we have shifted our strategy to operate Ballengee ~~Group~~, our recently acquired baseball agency, and to continue to develop our ~~Adapti.io~~AdaptAI artificial intelligence platform. Our ability to successfully implement this new business plan is unproven and involves substantial risks and uncertainties, including:

● Successfully integrating and growing Ballengee ~~Group~~, in a competitive and regulated industry; ● Developing and commercializing AdaptAI, which is intended to match social media influencers with Ballengee athletes and other products and services; and ● Demonstrating that these two different lines of business can operate synergistically to produce meaningful revenue growth.

●If we ~~Developing~~are unable to successfully operate our new business plan, develop and ~~commercializing~~achieve ~~Adapti.io~~successful results for AdaptAI, ~~which~~for isthe ~~intended~~benefit of toour ~~match~~athletes, ~~social~~or ~~media~~realize ~~influencers~~synergies with Ballengee ~~athletes~~Group, ~~and~~we ~~other~~may ~~products~~fail ~~and~~to ~~services;~~generate ~~and~~meaningful revenue or achieve profitability. Investors in our securities may lose some or all of their investment.

●As ~~Demonstrating~~part ~~that~~of ~~these~~our ~~two~~business ~~different~~plan, ~~lines~~we ofmay ~~business~~from ~~can~~time to ~~operate~~time ~~synergistically~~enter into binding and nonbinding term sheets or letters of intent to ~~produce~~acquire ~~meaningful~~other ~~revenue~~businesses ~~growth~~that relate to our operations.

~~If we~~Periodically, ~~are~~pursuant ~~unable~~ to ~~successfully operate~~ our ~~new~~ business plan, ~~develop~~we ~~and~~may enter ~~achieve~~into ~~market~~term ~~adoption~~sheets ~~for~~or ~~Adapti.io~~letters of intent, orboth ~~realize~~binding ~~synergies~~and nonbinding, to acquire businesses that relate to the operations of Adapti ~~with~~and Ballengee. ~~Group~~For example in October 2025, we ~~may~~entered ~~fail~~into a letter of intent to ~~generate~~acquire ~~meaningful~~Levelution ~~revenue~~Sports, orwhich ~~achieve~~represents ~~profitability~~NIL athletes, along with providing compliance, brand partnerships, and athlete development services. ~~Investors~~There incan ~~our~~be ~~securities~~no ~~may~~assurances ~~lose~~that ~~some or~~we ~~all~~will complete any of ~~their~~these ~~investment~~transactions, and if completed, whether we will be able to integrate such businesses into the Company.

Our business depends on the success of new and unproven initiatives, including the development of our ~~Adapti.io~~AdaptAI AI platform, and our ~~ability~~ ability to generate revenues is highly uncertain.

Our revenue model is unproven and difficult to predict. We intend to generate revenue primarily through:

● Athlete representation and related fees from Ballengee ~~Group~~; and ● Commissions or fees earned through social media promotions and influencer marketing, which we have yet to achieve.

●Each of ~~Commissions~~these orstrategies ~~fees~~involves ~~earned~~significant ~~through~~uncertainty. ~~social~~If ~~media~~developed, ~~promotions~~the ~~and~~success ~~influencer~~of ~~marketing,~~our ~~which~~AdaptAI weplatform ~~have~~will ~~yet~~depend toon ~~achieve;~~a ~~and~~number of factors outside our control, including:

● IfThe ~~and~~willingness ~~when~~of ~~developed,~~influencers ~~the~~and ~~commercialization~~athletes ofto retain our ~~AI-driven~~marketing ~~Adapti~~and representation services.io; ● The ability of the platform to derive and provide meaningful data regarding influencer / athlete activity and engagement; ● The effectiveness of social media promotions in generating consumer engagement and sales; and ● Rapidly changing public tastes and technology trends in both sports representation and influencer marketing.

~~Each of these strategies involves significant uncertainty. If developed, the success of our Adapti.io platform will depend on a number of factors outside our control, including:~~37

● The willingness of influencers and athletes to adopt the platform;

● The effectiveness of social media promotions in generating consumer engagement and sales; and

● Rapidly changing public tastes and technology trends in both sports representation and influencer marketing.

There is no guarantee that we will be able to successfully operate Ballengee Group or that the assumed synergies will be successful.

We recently completed the acquisition of Ballengee ~~Group~~, which we believe has the potential to be transformative for our Company. Management anticipates that Ballengee ~~Group~~ could contribute significantly to our revenues and help us achieve profitability. However, there can be no assurance that we will be able to maintain or grow Ballengee ~~Group~~’s historical business operations, revenues, or profitability.

Successfully realizing the anticipated synergies from this acquisition depends on our ability to:

● Integrate Ballengee ~~Group~~’s operations into our Company without significant disruption; ● Retain key athlete clients and personnel critical to Ballengee’s business; and ● Successfully develop and leverage our AdaptAI AI software to generate social media promotional opportunities for Ballengee’s athletes.

●Because AdaptAI ~~Retain~~is ~~key~~still ~~athlete~~in ~~clients~~development and ~~personnel~~unproven ~~critical~~in the market, there is no guarantee that it will generate the expected incremental revenues or competitive advantages. If we fail to integrate Ballengee Group’s effectively or achieve the assumed synergies, our business;, financial condition, and results of operations could be materially adversely affected, and investors could lose part or all of their investment.

● Successfully develop and leverage our Adapti.io AI software to generate social media promotional opportunities for Ballengee Group’s athletes.

Because Adapti.io is still in development and unproven in the market, there is no guarantee that it will generate the expected incremental revenues or competitive advantages. If we fail to integrate Ballengee Group effectively or achieve the assumed synergies, our business, financial condition, and results of operations could be materially adversely affected, and investors could lose part or all of their investment.

As a result, the Company believes that its results of operations may fluctuate significantly, and it is possible that the Company’s operating results could be below the expectations of investors.

Our AI based Social Media Software, ~~Adapti~~AdaptAI, is critical for the marketing and growth of our products

We have spent the past 3 years developing our ~~adapti.io~~AdaptAI technology platform to assist in locating and negotiating promotional arrangements with social media influencers. Although the ~~adapti.io~~AdaptAI platform has successfully completed beta testing, there is no guarantee that the software will operate as expected in a production environment or be able to provide us with assistance in obtaining the correct influencer to successfully market our services and clients. Further, there can be no assurance that the AdaptAI ~~adapti.io~~ will be as valuable to ~~the~~our ~~Ballengee Group~~ business as we anticipate. If the software does not work as expected, the ability to ~~sell our products and~~ promote our clients will be negatively impacted.

InManagement estimates that we will need approximately $250,000 complete development of AdaptAI. There is no certainty that we will raise sufficient capital or have sufficient profits to complete development of AdaptAI. In addition, if ~~adapti.io~~AdaptAI does not work as expected, we might be required to spend additional capital in software development. There are no guarantees that we will have the capital to spend in development or be able to get the software to work as desired even if we do spend additional capital. We also expect that we will need to spend additional capital in the future to further improve and maintain our software. There are no guarantees that we will have this capital to spend nor be able to successfully make the improvement as desired even if we do spend such capital.

2638

Risks Related to Our Business

We depend on the relationships of our agents, managers, and other key personnel with clients in professional sports and sponsorships and brands related thereto.

We depend upon relationships that our agents, managers, and other key personnel have developed with clients across the baseball industry. The relationships that our agents, managers, and other key personnel have developed with studios, brands, and other key business contacts help us to secure access to sponsorships, endorsements, professional contracts, and other opportunities for our clients. Due to the importance of those industry contacts to us, a substantial deterioration in these relationships, or substantial loss of agents, managers, or other key personnel who maintain these relationships, could adversely affect our business. In particular, our client management business is dependent upon the highly personalized relationships between our agents and respective clients. A substantial deterioration in the Ballengee Group’s management of a client may result in a deterioration in our relationship with, or the loss of, the clients represented by that agent or manager. The substantial loss of multiple agents or managers and their associated clients could have an adverse effect on our business, financial condition, and results of operations. Most of our agents, managers, and other key personnel are not party to long-term contracts and, in any event, can leave our employment with little or no notice. We can give no assurance that all or any of these individuals will remain with us or will retain their associations with key business contacts.

Because our success depends substantially on our ability to maintain a professional reputation, adverse publicity concerning us, one of our businesses, our clients, or our key personnel could adversely affect our business.

Our professional reputation is essential to our continued success and any decrease in the quality of our reputation could impair our ~~ability~~ ability to, among other things, recruit and retain qualified and experienced agents, managers, and other key personnel, retain or attract agency clients or customers, or enter into multimedia, licensing, and sponsorship engagements for the benefit of our clients. Our overall reputation may be negatively impacted by a number of factors, including negative publicity concerning us, members of our management or our agents, managers, and other key personnel. In addition, we are dependent for revenue, on the relationships between clients that we represent and key brands, such as sports leagues and other consumer facing brands. Certain of our clients are public personalities with social media followings whose actions generate publicity and public interest. Any adverse publicity relating to such individuals, or to our company, including from reported or actual incidents or allegations of illegal or improper conduct, such as harassment, discrimination, or other misconduct, could result in significant media attention, even if not directly relating to or involving Ballengee ~~Group~~ or Adapti, and could have a negative impact on our professional reputation. This could result in termination of licensing or other contractual relationships, or our employees’ ability to attract new customer or client relationships, or the loss certain clients, all of which could adversely affect our business, financial condition, and results of operations.

Our success depends, in part, on our continuing ability to identify, recruit, and retain qualified and experienced agents and managers.

If we fail to recruit and retain suitable agents or if our relationships with our agents change or deteriorate, it could adversely affect our business. Our success depends, in part, upon our continuing ability to identify, recruit, and retain qualified and experienced agents and managers. There is great competition for qualified and experienced agents and managers in the sports industry, and we cannot assure you that we will be able to continue to hire or retain a sufficient number of qualified persons to meet our requirements, or that we will be able to do so under terms that are economically attractive to us. Any failure to retain certain agents and managers could lead to the loss of our baseball clients, their sponsorships, and potential licensing agreements, and other engagements and have an adverse effect on our business, financial condition, and results of operations.

Our failure to identify, sign, and retain clients could adversely affect our business.

We derive substantial revenue from the engagements, sponsorships, licensing rights, and distribution agreements entered into by the baseball clients with whom we represent. We depend on identifying, signing, and retaining as clients those athletes whose identities are in high demand by the public and, as a result, are deemed to be favorable candidates for engagements. Our competitive position is dependent on our continuing ability to attract, develop, and retain clients whose work is likely to achieve a high degree of value and recognition by sponsors as well as our ability to provide such clients with sponsorships, endorsements, professional contracts, and other opportunities. Our failure to attract and retain these clients, an increase in the costs required to attract and retain such clients, or an untimely loss or retirement of these clients could adversely affect our financial results and growth prospects. These clients may decide to discontinue their relationship with us at any time and without notice. In addition, the clients with whom we have entered into written contracts may choose not to renew their contracts with us on reasonable terms or at all or they may breach or seek to terminate these contracts. If any of our clients decide to discontinue their relationships with us, whether they are under a contract or not, we may be unable to recoup costs expended to develop and promote them and our financial results may be adversely affected. Further, the loss of such clients could lead other of our clients to terminate their relationships with us.

Our professional athlete clients are also members of certain unions that are signatories to collective bargaining agreements. Any expiration, termination, revocation or non-renewal of these franchises, collective bargaining agreements, or licenses and any work stoppages or labor disturbances could adversely affect our business.

Our professional athlete clients are subject to collective bargaining and/or franchise agreements. These collective bargaining and/or franchise agreements regularly expire and require negotiation in the ordinary course of business. Upon the expiration of any of these collective bargaining and/or franchise agreements, with no assurance that the unions will be able to negotiate new collective bargaining and/or franchise agreements on satisfactory terms or at all. Our operations may be interrupted as a result of labor disputes or difficulties and delays in the process of renegotiating. Certain of such unions have in the past gone on strike, and in the future may do so again. We cannot predict the effect that a potential work stoppage would have on our business. The Ballengee Group business is a signatory to certain agreements with the unions that represent certain of its clients (for example, with the Major League Baseball Players association).

2739

Unauthorized disclosure of sensitive or confidential client or customer information could harm our business and standing with our clients and customers.

We seek to protect trade secrets, confidential information, personal information and other proprietary information, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to such information, such as our employees, collaborators, contractors, consultants, advisors and other third parties. However, we cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or proprietary technology, information and processes. Further, despite these efforts, no assurance can be given that these agreements will be effective in controlling access to and distribution of our products and proprietary information as any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches.

Prosecuting a claim that a party illegally disclosed or misappropriated a trade secret or confidential information is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts within and outside of the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position could be materially and adversely harmed.

Changes in public and consumer tastes and preferences and industry trends could reduce demand for our services and ~~content offerings and~~ adversely affect our business.

Our ability to generate revenues is highly sensitive to rapidly changing consumer preferences and industry trends, as well as the popularity of the talent, brands, and owners of intellectual property we represent, and the assets we own. Our success depends on our ability to ~~offer~~represent ~~premium~~influencers ~~content~~and ~~through~~athletes ~~popular~~and ~~channels~~successfully ofmatch ~~distribution~~them ~~that~~with ~~meet~~endorsements and marketing opportunities that meet the changing preferences of the broad consumer market. ~~and~~With ~~respond~~respect to ~~competition~~endorsements ~~from~~and anmarketing ~~expanding array~~ of ~~choices~~our ~~facilitated~~athletes ~~by technological~~and ~~developments~~influencers, inour ~~the delivery of content. Our~~ operations and revenues ~~are~~will be affected by consumer tastes and entertainment trends. Changes in consumers’ tastes or a change in the perceptions of ~~our~~marketing ~~brands~~ and ~~business partners~~endorsements, whether as a result of the social and political climate or otherwise, could adversely affect our operating results. ~~Our~~The failure of our represented clients to avoid a negative perception among consumers ~~or anticipate and respond to changes in consumer preferences, including in the form of content creation or distribution,~~ could result in reduced demand for our ~~services~~marketing and ~~content~~endorsement ~~offerings or those of our clients and owned assets across our platform~~services, which could have an adverse effect on our business, financial condition and results of operations.

We may not be able to adapt to or manage new content distribution platforms or changes in consumer behavior resulting from new technologies.

We must successfully adapt to and manage technological advances in our industry, including the emergence of alternative distribution platforms and artificial intelligence. Our ability to effectively generate revenue from new distribution platforms and viewing technologies will affect our ability to maintain and grow our business. Emerging forms of content distribution may provide different economic models and compete with current distribution methods in ways that are not entirely predictable, which could reduce consumer demand for our product offerings. We must also adapt to changing consumer behavior driven by advances in content delivery and mobile devices. If we fail to adapt our distribution methods and content to emerging technologies and new distribution platforms, it could result in an adverse effect on our business, financial condition, and results of operations.

We, including our subsidiaries, may be unsuccessful in our strategic acquisitions, investments and commercial agreements, and we may pursue acquisitions, investments or commercial agreements for their strategic value in spite of the risk of lack of profitability.

We, including our subsidiaries, face significant uncertainty in connection with acquisitions, investments, and commercial agreements. To the extent we choose to pursue certain commercial, investment, or acquisition strategies, we may be unable to identify suitable targets for these deals, or to make these deals on favorable terms. If we identify suitable acquisition candidates, investments, or commercial partners, our ability to realize a return on the resources expended pursuing such deals, and to successfully implement or enter into them will depend on a variety of factors, including our ability to obtain financing on acceptable terms, requisite governmental approvals, as well as the factors discussed below. Additionally, we may decide to make or enter into acquisitions, investments, or commercial agreements with the understanding that such acquisitions, investments, or commercial agreements will not be profitable, but may be of strategic value to us. Our current and future acquisitions, investments, including existing investments accounted for under the equity method, or commercial agreements may also require that we make additional capital investments in the future, which would divert resources from other areas of our business. We cannot provide assurances that the anticipated strategic benefits of these deals will be realized in the long-term or at all.

We may fail to identify or assess the magnitude of certain liabilities, shortcomings, or other circumstances prior to acquiring a company, making an investment or entering into a commercial agreement and, as such, may not obtain sufficient warranties, indemnities, insurance, or other protections. This could result in unexpected litigation or regulatory exposure, unfavorable accounting treatment, unexpected increases in taxes, a loss of anticipated tax benefits, or other adverse effects on our business, operating results, or financial condition. Additionally, some warranties and indemnities may give rise to unexpected and significant liabilities. Future acquisitions and commercial arrangements that we may pursue could result in dilutive issuances of equity securities and the incurrence of further debt.

2840

Risks Related to Competition; Personnel; and Financial Condition

We face competition from substantially larger and better-financed competitors in both our baseball agency and technology businesses.

We operate in two highly competitive industries: sports representation and technology/software development. In the baseball agency sector, numerous established sports agencies represent athletes, many with significantly greater resources, broader client rosters, and stronger relationships with teams and sponsors. In the technology sector, numerous companies market software and digital solutions for social media influencer management, including large, well-capitalized enterprises. The size, number, and resources of these competitors make it challenging for us to achieve and maintain market share in either business segment.

We depend on our management team to succeed, and the loss of their services could harm our business.

To achieve our objectives, we require a management team with expertise in software development, product development, sports representation, and sales and marketing. Although we recently appointed Jeff Campbell as our executive chairman, who has experience in sports agencies, the fitness industry, marketing and technology, we still have a limited management team. Although we have agreements with certain executive officers and outsourced programming consultants, these agreements may be terminated at any time. We do not maintain “key person” insurance for any of our executives or other employees, and competition for qualified personnel in our industries is intense. If we cannot attract and retain qualified personnel on acceptable terms, our growth and operations could be adversely affected.

We also owe accrued salary to our Chief Executive Officer and Chief Financial Officer, which may impact their continued service and ~~create~~ create financial and reputational risks. As of ~~June~~September 30, 2025, our Chief Executive Officer, Adam Nicosia, is owed approximately $~~120~~150,000 in accrued but unpaid salary, and our chief accounting officer and interim Chief Financial Officer, Marilu Brassington, is owed approximately $7095,000 There is no assurance that either executive will continue to provide services to the Company if delays in paying their full compensation persist. As of the date of this Quarterly Report on form 10-Q, we do not have sufficient capital to pay these accrued amounts. If either officer were to resign or reduce his or her involvement due to nonpayment, our operations, strategic direction, and ability to attract investors or key partners could be materially and adversely affected. Moreover, failure to pay accrued compensation may raise legal, accounting, and reputational concerns and could expose us to claims or liabilities under employment laws. We expect to attempt to satisfy the unpaid balances once we achieve sufficient profitability or raise additional capital, but there can be no assurance as to when or whether we will be able to do so.

Our Chief Executive Officer and Chief Financial Officer hold executive positions with other companies and may have limited time to devote to our business.

Our Chief Executive Officer and Chief Financial Officer each work on a part-time basis for us and also serve as officers of other companies. As a result, they divide their professional time among multiple business interests. This arrangement may limit the time and attention they can devote to our operations, strategic initiatives, and day-to-day management. Their other professional obligations could create actual or potential conflicts of interest and may delay or hinder decision-making, responsiveness to business opportunities, or the execution of our growth strategies, any of which could materially and adversely affect our business and results of operations.

Obligations under the participating promissory notes issued in the Ballengee acquisition will reduce the proceeds available from future capital raises and may limit the use of our cash flows.

In connection with our acquisition of the Ballengee ~~Group~~, we issued a participating promissory notes in the aggregate principal amount of $7,500,000 to the sellers. These notes require us to make mandatory repayments equal to (i) 10% of the gross proceeds from any offering of our equity securities that results in at least $250,000 in gross proceeds, and (ii) 50% of the free cash flows generated by Ballengee Group’s operations each calendar quarter, with the percentage reducing over time as principal is repaid.

As a result, if we complete any equity offering, or if Ballengee generates positive cash flow, a portion of those proceeds or cash flows will be required to be paid to the former Ballengee owners rather than being available to fund our operations, invest in growth initiatives, or pursue other strategic opportunities. This repayment obligation could materially and adversely affect our liquidity, limit our ability to reinvest in the business, and reduce our financial operations. In addition, because the amount and timing of these payments depend on our capital-raising activities and Ballengee’s performance, we may be required to make payments at times when we would otherwise use those funds for other purposes, which could further strain our working capital and operating resources.

2941

We may be required to pay certain earnout consideration payable to the former Ballengee Group owners could result in significant future stock issuances and dilution to our stockholders.

Under the terms of the acquisition of Ballengee ~~Group~~, the former owners of Ballengee are entitled to receive up to $20,000,000 in additional earnout consideration over a four-year period beginning January 1, 2025 and ending December 31, 2028, payable in shares of our common stock if certain EBITDA targets are met by Ballengee Group’s operations as follows: for each earnout year, (i) no payment will be made if Ballengee’s EBITDA is below $2,000,000, (ii) a payment equal to actual EBITDA will be made if EBITDA is between $2,000,000 and $5,000,000, and (iii) a payment of $5,000,000 will be made if EBITDA is at least $5,000,000.

If Ballengee achieves the specified EBITDA metrics above, we will be required to issue a potentially substantial number of shares of our Common Stock, which would dilute the ownership interests of our existing stockholders. This dilution could be significant, particularly if our stock price declines, as more shares would be required to satisfy the earnout obligation. The possibility of future substantial issuances of our Common Stock in connection with the earnout may also create downward pressure on our stock price. In addition, the earnout obligation could incentivize management to focus on achieving the specific EBITDA targets at the expense of other strategic initiatives or long-term value creation.

In addition to our outstanding indebtedness, we also have pledged substantially all of the assets of Ballengee pursuant to loan agreement. and our debt obligations expose us to risks that could adversely affect our business, operating results and financial condition. We will need to raise additional capital to pay our indebtedness as it comes due.

On November 6, 2025, Ballengee entered into a revolving line of credit for up to $3,000,000 (“Revolving Loan”) with Texas Security Bank. Additionally, 2278 Monitor, LLC (“2278”), an entity controlled by James Ballengee, our majority shareholder, entered into a revolving line of credit for up to $2,000,000, secured by 2278’s real property holdings. As of November 15, 2025, zero dollars have been drawn down off of the Revolving Loan by Ballengee. All amounts due under the Revolving Loan are secured by substantially all of the assets of Ballengee. Additionally, Ballengee entered into a cross collateralization agreement whereby any default under loans entered into by 2278, by real property will result in a default under the Revolving Loan. Commencing in December 2025, we are required to begin making interest payments on such indebtedness until February 28, 2027 (the “Maturity Date”), at which time all principal is due and payable. As security for such indebtedness, Ballengee pledged substantially all of its assets, including current and future receivables, inventory, intellectual property, etc.

In addition, we have as of November 15, 2025, we have approximately $689,549 in outstanding convertible notes including accrued interest that are due and payable at various times in 2026. While the holders may convert these instruments into capital stock of the Company, we may be required to make substantial interest and principal payments at maturity. Given that the Company is not currently profitable, there can be no assurance that we will generate sufficient revenue or cash flow, or obtain additional financing on favorable terms, for us to satisfy these obligations when due. If we are unable to repay, refinance, or restructure our outstanding indebtedness, we could be forced to sell assets, issue additional equity securities at dilutive prices, or seek protection under bankruptcy or insolvency laws. Any such events could materially and adversely affect our business, financial condition, results of operations, and the value of your investment.

Additionally, in the event that we fail to make payments when due under the Revolving Loan or our majority shareholder fails to make payments under the 2278 loans, or if we fail to comply with the various requirements and covenants to the Revolving Loan, we would be in default, which would permit the lender to accelerate the maturity and require immediate repayment. Additionally, the Revolving Loan contains a number of affirmative and restrictive covenants, including reporting requirements, and certain limitations. Our failure to comply with such requirements could result in an event of default that, if not cured or waived, could result in the acceleration of the debt and potential foreclosure on the assets pledged to secure the debt. If we are unable to refinance or repay our indebtedness as it becomes due or upon an event of default, we may become insolvent and be unable to continue operations.

We have expressed substantial doubt about our ability to continue as a going concern.

Management has determined that there is substantial doubt about our ability to continue as a going concern for a period of one year following the issuance of this report. This determination was based on conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued, including the probability that significant changes to our anticipated level of operations, due to factors that are within or outside of our control, would cause our available cash as of the date of this filing to not be sufficient to fund our anticipated level of operations for the next 12 months. Our future consolidated financial statements may include a similar qualification about our ability to continue as a going concern. Our year-end and interim consolidated financial statements were prepared assuming that it will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty.

If we seek additional financing to fund our business activities in the future and there remains substantial doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding to us on commercially reasonable terms or at all.

Our auditors have expressed substantial doubt about our ability to continue as a going concern.

Our auditors’ report on our consolidated financial statements for the year ended March 31, 2025 expressed an opinion that we had a working capital deficit of $1,030,775 as the year end and have incurred losses and not yet generated significant revenue from our operations and that we will require additional funds to maintain our operations. Our current cash level raises substantial doubt about our ability to continue as a going concern past the quarter ending on ~~June~~September 30, 2025. If we do not obtain additional funds by such time, we may no longer be able to continue as a going concern and may need to cease operations which means that our shareholders will lose their entire investment.

Our business requires a substantial investment of capital, and we have limited working capital and limited access to financing;

The promotion and marketing of our products and services, along with the continued development and enhancement of our ~~adapti.io~~AdaptAI software platform, require significant capital. Following the closing of our acquisition of the Ballengee ~~Group~~, we also require substantial additional capital to operate and grow the sports agency business. Our cash requirements are expected to exceed the level of cash generated by ~~operations~~ operations for the foreseeable future, and we may have limited working capital. Capital available for growth initiatives will be reduced to the extent we must use funds budgeted for investment to fund day-to-day operations. Sustained reductions in investment could materially ~~and~~ and adversely affect future operating results and cash flows. In addition, a significant amount of time may elapse between our expenditure of funds and the receipt of revenues from our operations, particularly in the baseball agency business, where contract cycles and commission payments may occur months or years after player representation efforts begin. This timing gap requires us to fund a significant portion of our capital needs from operating cash flow and other financing sources.

3042

Our ability to obtain additional financing on satisfactory terms may be limited. For equity financing, our ability to raise capital depends on general market conditions and investor demand for our securities. We may be unable to raise capital through equity offerings, and any such financing could cause substantial dilution to our existing stockholders. If we raise additional funds through the issuance of equity, equity-linked, or debt securities, those securities may have rights, preferences, or privileges senior to those of our common stock. If adequate financing is not available at all or is unavailable on acceptable terms, we may be unable to fund expansion, sustain operations, pursue acquisitions, develop or enhance products and services, or respond effectively to competitive pressures. Any of these outcomes could materially and adversely affect our business, financial condition, results of operations, liquidity, and prospects.

Risks Related to Technology

Use of Artificial Intelligence in ~~adapti.io~~AdaptAI Presents Operational, Legal, Ethical, and Competitive Risks.

We are developing our ~~adapti.io~~AdaptAI platform to incorporates artificial intelligence and machine learning technologies to provide certain ~~features~~ features and functionality. The development, training, and operation of AI models depend on the quality, accuracy, and representativeness of the data used. Inaccurate, incomplete, or biased data sets may result in flawed outputs, which could reduce the effectiveness of our services, lead to incorrect conclusions or recommendations, and harm our reputation.

The use of AI presents emerging legal and regulatory risks. Governments in the United States, the European Union, and other jurisdictions are considering or have enacted legislation regulating the development and use of artificial intelligence. These evolving laws and regulations could impose additional compliance obligations, increase costs, restrict certain applications, or potentially subject us to fines, penalties, or other liabilities.

Artificial intelligence technologies are rapidly evolving, and competitors, including those with greater resources, may develop more advanced tools or features. Our ability to maintain a competitive advantage depends on our ongoing investment in research and development related to our ~~Adapti.io~~AdaptAI ~~tool~~platform, access to high-quality training data, and protection of our intellectual property. Additionally, some aspects of ~~Adapti.io~~AdaptAI may not be eligible for copyright protection, and we may face claims from third parties alleging that our platform infringes on their rights.

Cybersecurity Breaches, Data Loss, or System Failures Could Disrupt ~~adapti.io~~AdaptAI’s Operations, Compromise Sensitive Information, and Harm Our Reputation.

Our ~~adapti.io~~AdaptAI platform relies on the secure collection, storage, processing, and transmission of proprietary, confidential, and personal data. We face cybersecurity risks, including malware, ransomware, denial-of-service attacks, phishing, supply chain attacks, and other unauthorized attempts to gain access to our systems or data. Cyberattacks are becoming increasingly sophisticated and may be conducted by well-funded state-sponsored actors, organized crime groups, or other threat actors.

A successful breach of our systems, or those of our third-party service providers, could result in the theft, destruction, loss, unauthorized disclosure, or alteration of proprietary or confidential information, including personal data of clients, users, and employees. Such an event could disrupt the operation of ~~adapti.io~~AdaptAI, result in legal and regulatory liability, damage our reputation, lead to a loss of clients or business opportunities, and require significant resources to investigate and remediate.

We also rely on third-party hosting and cloud service providers to operate ~~adapti~~AdaptAI.~~io.~~ Outages, vulnerabilities, or security incidents at these providers could likewise result in downtime, data loss, or compromise. While we have implemented security measures designed to protect our systems and data, these measures may be inadequate or may become outdated as threats evolve. Our insurance coverage may be insufficient to compensate for any losses resulting from a cybersecurity incident. Any significant disruption or security breach could materially and adversely affect our business, financial condition, and results of operations.

Risk Related to Ownership of our Securities and Government Regulation

Concentration of Ownership Following the Ballengee Group Acquisition Gives Certain Stockholders the Ability to Control or Significantly Influence Corporate Decisions.

Following the completion of the Ballengee Group acquisition, the former principals of Ballengee Group own in excess of 80% of our outstanding Common Stock, giving them the ability to control or significantly influence the election of directors, approval of significant corporate transactions, and other matters requiring stockholder approval. This concentration of ownership may delay, deter, or prevent a change in control of our Company, even if such a change of control would benefit our other stockholders, and could limit your ability to influence corporate matters.

In addition, this level of ownership concentration could discourage potential acquirers from making an offer to purchase our Company, may result in the approval of actions that other stockholders do not view as beneficial, and could adversely affect the market price of our common stock if investors perceive the ownership concentration as limiting the value or liquidity of their shares.

Our authorized capital structure allows for the issuance of a substantial number of additional shares, which could result in significant dilution to existing stockholders.

Our articles of incorporation, as amended, authorizes the issuance of up to 40,000,000,000 shares of Common Stock and 20,000,000 shares of “blank check” preferred stock. The preferred stock may be issued in one or more series, with such rights, preferences, privileges, ~~and~~ and restrictions (including voting, dividend, conversion, redemption, and liquidation rights) as may be determined by our board of directors without further stockholder approval. As of ~~August~~November 1, 2025, we had 8,039,259 shares of Common Stock outstanding and no preferred stock outstanding. In addition, we had approximately $~~277~~284,~~967~~520 in outstanding convertible promissory notes and $~~217~~2,~~096~~574,910 in outstanding related party notes payable, which are convertible, including accrued interest, into approximately ~~160~~928,~~735~~386 shares of Common Stock as of that date.

3143

In addition, pursuant to our acquisition of the Ballengee ~~Group~~, we are obligated to issue shares of Common Stock up to a maximum of $20,000,000 in value as part of potential earnout consideration if certain EBITDA performance targets are achieved by the Ballengee ~~Group~~. The number of shares to be issued will be based on the then-current volume weighted average trading price of our Common Stock for the ten (10) day period immediately preceding the end of each calendar year. A decline in our stock price during the earnout measurement periods could result in the issuance of a significantly greater number of shares, increasing dilution to our existing stockholders.

Because our board of directors has broad authority to issue additional common stock, preferred stock, or securities convertible into or exercisable for such shares without further stockholder action (except as may be required by applicable law or the rules of any securities exchange on which our securities may be listed), any such issuances could dilute the ownership interests of existing stockholders, adversely affect the trading price of our Common Stock, and, in the case of preferred stock, grant rights superior to those of the holders of our Common Stock.

It is likely that we will need to issue a large number of additional securities to raise capital in order to further our business plans. It is also likely that we will issue a large number of additional securities to directors, officers, employees and consultants as compensatory grants in connection with their services. These issuances would dilute the percentage ownership interest of our current shareholders, which would have the effect of reducing your influence on matters on which our stockholders vote, and might dilute the net tangible book value per share of our common stock.

The market for our common stock has historically been illiquid and our investors may be unable to sell their shares.

Our Common Stock has historically traded with limited volume on the pink tier of the OTC Markets. Accordingly, although there is a public market for our Common Stock, it still is, and has, historically been relatively illiquid compared to that of a seasoned issuer. Prior to making an investment in our securities, you should consider the historically limited market for our Common Stock. No assurances can be given that the trading volume of our Common Stock will increase or remain the same.

We have not paid cash dividends in the past and do not expect to pay cash dividends in the foreseeable future.

We have never paid cash dividends on our Common Stock and do not anticipate paying cash dividends on our Common Stock in the foreseeable future. If we do not pay dividends, our Common Stock may be less valuable because a return on your investment will only occur if the market price of our Common Stock appreciates.

Our operations are subject to federal, state and local laws, statutes, rules, regulations, policies, and procedures in the United States, which are subject to change at any time, governing matters such as our representation of professional baseball players, licensing laws for athlete agents, and compliance with cybersecurity laws.

Noncompliance with these laws could subject us to complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, reputational harm, and other collateral consequences. Multiple or repeated failures by us to comply with these laws and regulations could result in increased fines or proceedings against us, including suspension or revocation proceedings relating to licenses we are required to maintain to conduct the business of Ballengee Group. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, results of operations, and financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management’s attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm our business, results of operations, and financial condition. There can be no assurance that a law or regulation will not be interpreted or enforced in a manner contrary to our current understanding. In addition, the promulgation of new laws, rules, and regulations could restrict or unfavorably impact our business, which could decrease demand for our services, reduce revenue, increase costs, or subject us to additional liabilities.

We may have direct and indirect interactions with government agencies and state affiliated entities in the ordinary course of operating the Ballengee Group business. In the event that we fail to comply with the regulations of a particular jurisdiction, whether through our acts or omissions or those of third parties, it may have an adverse effect on our business, financial condition, and results of operations.

3244

We may be unable to comply with our reporting and other requirements under federal securities laws.

The Sarbanes-Oxley Act of 2002, as well as related new rules and regulations implemented by the United States Securities and Exchange Commission, or SEC, and the Public Company Accounting Oversight Board, require changes in the corporate governance practices and financial reporting standards for public companies. These laws, rules and regulations, including compliance with Section 404 of the Sarbanes-Oxley Act of 2002 relating to internal control over financial reporting, would be expected to materially increase the Company’s legal and financial compliance costs and make some activities more time-consuming and more burdensome. Presently we qualify as a non-accelerated filer. Accordingly, we are exempt from the requirements of Section 404(b) and our independent registered public accounting firm is not required to audit the design and operating effectiveness of our internal controls and management’s assessment of the design and the operating effectiveness of such internal controls. In the event that we become an accelerated filer, we will be required to expend substantial capital in connection with compliance.

We do not have effective internal controls over our financial reporting.

Because of our limited resources, management has concluded that our internal control over financial reporting may not be effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Effective internal controls over financial reporting and disclosure controls and procedures are necessary for us to provide reliable financial and other reports and effectively prevent fraud. If we cannot provide reliable financial or SEC reports or prevent fraud, investors may lose confidence in our SEC reports, our operating results and the trading price of our common stock could suffer materially, and we may become subject to litigation.

Compliance with changing regulation of corporate governance and public disclosure may result in additional expenses and will divert time and attention away from revenue generating activities.

Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002 and related SEC regulations, have created uncertainty for public companies and significantly increased the costs and risks associated with accessing the public markets and public reporting. Our management team invests significant time and financial resources to comply with both existing and evolving standards for public companies, which will lead to increased general and administrative expenses and a diversion of management time and attention from developing our business to compliance activities which could have an adverse effect on our business.

We are a “smaller reporting company” and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our securities less attractive to investors.

We are a “smaller reporting company,” as defined in Rule 12b-2 under the Exchange Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including “emerging growth companies” such as, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Our status as a smaller reporting company is determined on an annual basis. We cannot predict if investors will find our securities less attractive or our Company less comparable to certain other public companies because we will rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future financial results may not be as comparable to the financial results of certain other companies in our industry that adopted such standards.

3345

Item 2. Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

1. On ~~July~~September 1415, 2025, ~~the~~in ~~Company~~exchange ~~entered~~for ~~into an amended and restated membership interest purchase agreement (the “Purchase Agreement”) with BSG Holdings~~$150, ~~LLC and JBAH Holdings~~000, ~~LLC (“Sellers”), pursuant to which~~ the Company ~~acquired,~~entered ~~from~~into ~~the Sellers, 100% of the outstanding membership interests (“Membership Interests”) of Ballengee Group, LLC,~~ a ~~Texas-based sports agency~~17.5% ~~Pursuant~~original toissue ~~the~~discount ~~Purchase~~senior ~~Agreement,~~convertible aspromissory ~~consideration~~note for the acquisition of the Membership Interests, the Sellers received: (i) an aggregate of 6,500,000 shares of the Company’s Common Stock valued at $20,000,000, based on the volume-weighted average price per share of the Common Stock for the ten trading days prior to July 14, 2025, (ii) a ~~participating~~face ~~promissory~~value ~~note in the aggregate principal amount~~ of $7181,500,000 (the “Participating Note”), and (iii) the right to receive future earnout consideration of up to $20,000,000, to paid over a four (4) year period on the achievement of certain milestones by Ballengee as a stand-alone entity post-acquisition (the “Earnout Consideration”818. The ~~transaction closed on July 14, 2025. The Participating~~ Note ~~matures on June 30, 2030,~~ has an interest rate of five percent (5%) per annum, and receives mandatory payments (i) in the event the Company completes an offering of securities resulting in gross proceeds of at least $250,000 and (ii) from free cash flow generated by Ballengee as a ~~standalone~~maturity ~~entity.~~date ~~The Earnout Consideration is payable in shares~~ of ~~Common~~December ~~Stock of the Company based on Ballengee meeting certain EBITDA as a stand-alone entity. 2. In connection with her new employment agreement, on August~~ 14, 2025, weand ~~issued~~begins ~~Ms. Brassington a non-qualified stock option grant~~ to ~~purchase~~accrue upinterest ~~to 120,000 shares of Common Stock~~ at a20% ~~price~~ per ~~share~~90 ofday ~~$3.08 . The option has a term of 10 years from issuance, and vests in four (4) equal annual installments over a four (4) year~~ period, ~~with~~beginning ~~such first vesting event occurring~~ on the one (1) year anniversary of the grant date. 3. On August 14, 2025, we issued Ms. Brassington, our principal accounting officer and interim chief financial officer, a subordinated convertible promissory note in principal of $184,800. The note has a maturity date ~~of three (3) years from issuance~~, ~~accrues~~if ~~interest~~not atrepaid ~~the~~or ~~rate~~converted ~~of 5% per annum, and is payable in full at maturity The note is also convertible~~ into ~~Common~~common ~~Stock~~stock ~~at the holder’s election at any time at a conversion price~~ of ~~$3.08 per share. Additionally, at maturity,~~ the Company ~~has the right to require holder to convert the note into shares of Common Stock at a conversion price of $3~~.08 ~~per share. 4. On August 14, 2025, we issued Jeff Campbell, our executive chairman, a subordinated convertible promissory note in principal of $492,800.~~ The note has a maturity date of three (3) years from issuance, accrues interest at the rate of 5% per annum, and is payable in full at maturity. The note is also convertible into Common Stock at the holder’s election at any time at a conversion price ~~of $3.08~~ per share. ~~Additionally,~~is atequal ~~maturity, the Company has the right~~ to ~~require holder to convert~~ the ~~note~~lesser ~~into shares~~ of ~~Common~~(i) ~~Stock at a conversion price of~~ $3.08 ~~per~~and ~~share. 5. On August 14, 2025, we issued Adam Nicosia, our chief executive officer, a subordinated convertible promissory note in principal of $1,478,400. The note has a maturity date of three~~ (3ii) ~~years~~70% ~~from issuance, accrues interest at the rate~~ of ~~5% per annum, and is payable in full at maturity. The note is also convertible into Common Stock at~~ the ~~holder’s~~closing ~~election at any time at a conversion~~ price of ~~$3.08 per share. Additionally, at maturity,~~ the ~~Company has the right to require holder to convert the note into shares of~~ Common Stock aton athe ~~conversion~~date ~~price~~ of $3conversion.08 ~~per~~The ~~share. 6. On April 28, 2025, we issued a convertible promissory~~ note towas anrepaid ~~investor~~ in ~~principal~~full offor $~~200~~181,~~000~~818 ~~plus~~on aNovember 10% financing fee against payment therefore. The note matures 12 months from issuance and is payable at maturity. The note has an interest rate of 10% per annum and contains an additional bridge fee or exit fee of 10% of the initial principal at repayment or conversion. At any time prior to maturity5, ~~the note is convertible into Common Stock at the holder’s election at a conversion price per share of $3.08.~~2025,

~~The~~2. ~~offers,~~In ~~sales~~connection ~~and~~with ~~issuances of~~ the ~~securities~~extension ~~described~~of ~~above~~maturity ~~were exempt~~dates ~~from registration under the Securities Act~~ of ~~1933,~~three ~~as amended, in reliance on Section 4~~(a3)~~(2)~~ ~~thereof~~convertible ~~and/or~~promissory ~~Rule~~notes, ~~506~~on ofNovember ~~Regulation D~~14, ~~promulgated~~2025, ~~thereunder as transactions not involving a public offering. The recipients represented that they were acquiring~~ the ~~securities for~~Company ~~investment~~issued ~~purposes only and not with a view to or for resale in connection with any distribution thereof, and appropriate legends were affixed to~~ the ~~securities,~~following ~~where~~shares ~~applicable. Each recipient was an “accredited investor” as defined in Rule 501(a)~~ of ~~Regulation~~ DCommon ~~and~~Stock ~~had access~~ to ~~information about~~ the ~~Company~~respective ~~necessary to evaluate the investment.~~lenders:

34● 5,000 shares of Common Stock valued at $14,500 on the date of issuance in exchange for extending the maturity date of a convertible promissory note issued on October 10, 2024 to extend the maturity from October 10, 2025 to April 10, 2026. ● 10,000 shares of Common Stock valued at $29,000 on the date of issuance in exchange for extending the maturity date of a convertible promissory note issued on October 30, 2024 to extend the maturity from October 30, 2025 to October 30, 2026. The shares were issued to Stuff International, Inc., an entity controlled by Adam Nicosia, our CEO. ● 10,000 shares of Common Stock valued at $29,000 on the date of issuance in exchange for extending the maturity date of a convertible promissory note issued on September 24, 2024 to extend the maturity from September 24, 2025 to September 24, 2026. The shares were issued to The Campbell Trust. Jeff Campbell, our executive chairman serves as the trustee for The Campbell Trust.

	3.	On November 5, 2025, the Company issued a consultant a warrant to purchase up to 8,000 shares of Common Stock at a price per share of $3.08, and a term of five (5) years. Of the shares underlying the warrant, 2,666 vest immediately, and 5,334 vest in eight (8) equal quarterly periods beginning on the one (1) year anniversary of the issuance date and ending on the three (3) year anniversary of the issuance date. The warrants were valued at an aggregate of $24,640 on the date of issuance.

	4.	Pursuant to the acquisition Ballengee, the Company may make rent monthly rent payments of $25,000 to an entity owned by James Ballengee in lieu of cash. Accordingly, for the months ending July, August, and September 2025, we issued an aggregate of 34,469 shares to Waskom Enterprises, LLC. The Shares were valued in the aggregate at a blended value of approximately $2.18 per share. The shares issued are subject to the lock-up agreement entered into by the Company and James Ballengee’s entities in connection with the acquisition of Ballengee Group, LLC.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

~~Employment Agreement and Related~~Not ~~Contracts with Marilu Brassington~~applicable

On August 14, 2025, we entered into a new employment agreement with Marilu Brassington, our current interim Chief Financial Officer (the “Brassington Employment Agreement”). Ms. Brassington was previously serving as our interim Chief Financial Officer without a written employment agreement. Pursuant to the Brassington Employment Agreement, Ms. Brassington will serve as the Company’s chief accounting officer and interim chief financial officer.46

~~Pursuant to the Brassington Employment Agreement, Ms. Brassington receives~~Item ~~an annual base salary of $180,000~~6. On each monthly anniversary of the Brassington Employment Agreement, the Company will pay half of her monthly base salary in Common Stock, valued at the closing price of the Comon Stock on such applicable date.Exhibits

We also agreed to issue Ms. Brassington a non-qualified stock option grant to purchase up to 120,000 shares of Common Stock at a price per share of $3.08 (the “Option”). The Option was issued on August 14, 2025, has a term of 10 years from issuance, and vests in four (4) equal annual installments over a four (4) year period, with such first vesting event occurring on the one (1) year anniversary of the grant date.

Exhibit Number		Exhibit Description
3.1*		Articles of Incorporation, as amended (incorporated by reference into Exhibit 3.1 of the Registrant’s Form 10-Q, filed with the SEC on August 14, 2025).
3.2		Bylaws, as amended (incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10, filed with the SEC on February 12, 2025).
10.1		Form of Amended and Restated Membership Interest Purchase Agreement dated July 14, 2025 among the Company, BSG Holdings, Inc. and JBAH Holdings, Inc. for the acquisition of Ballengee Group, LLC (incorporated by reference to Exhibit 10.01 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.2		Form of Participating Note dated July 14, 2025 issued in connection with the Ballengee Group, LLC acquisition (incorporated by reference to Exhibit 10.02 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.3		Form of Lock-Up Agreement entered into in connection with the Ballengee Group, LLC acquisition (incorporated by reference to Exhibit 10.03 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.4		Form of Promissory Note entered into by and between Campbell Trust (Jeff Campbell) and the Company dated September 25, 2024 (incorporated by reference to Exhibit 10.05 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.5		Form of Promissory Note entered into by and between Campbell Trust (Jeff Campbell) and Ballengee Group, LLC dated June 2, 2025 (incorporated by reference to Exhibit 10.06 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.6		Form of Consulting Agreement with Jeff Campbell to serve as Executive Chairman, dated June 30, 2025 (incorporated by reference to Exhibit 10.2 of the Registrant’s Form 10-K, filed with the SEC on July 3, 2025).
10.7		Form of Employment Agreement with Marilu Brassington dated August 14, 2025 (incorporated by reference to Exhibit 10.7 of the Registrant’s Form 10-Q filed with the SEC on August 14, 2025).
10.8		Form of Option issued to Marilu Brassington (incorporated by reference to Exhibit 10.8 of the Registrant’s Form 10-Q filed with the SEC on August 14, 2025).
10.9		Form of Subordinated Convertible Promissory Note issued to Marilu Brassington, Jeff Campbell (Campbell Trust), and Adam Nicosia (Stuff International) (incorporated by reference to Exhibit 10.9 of the Registrant’s Form 10-Q filed with the SEC on August 14, 2025).
10.10		Form of Convertible Promissory Note issued to various investors (incorporated by reference to Exhibit 10.10 of the Registrant’s Form 10-Q filed with the SEC on August 14, 2025).
10.11		Form of Amendment to Convertible Promissory Notes entered into by various lenders in November 2025.
10.12		Form of Common Stock Purchase Warrant to consultant in November 2025.
31.1 & 31.2*		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2003.
32.1 & 32.2**		Certifications of CEO And CFO Pursuant To Section 906 Of The Sarbanes-Oxley Act

~~Ms. Brassington also entered into the Company’s standard confidential~~* ~~information~~Filed ~~and invention assignment agreement governing the ownership of any inventions and confidential information.~~herewith

~~The foregoing summary of certain terms of the Brassington Employment Agreement~~** ~~and~~Furnished ~~Option are qualified in their entirety by the terms of the Brassington Employment Agreement and Option, copies of which are attached to this Quarterly Report on Form 10-Q as Exhibits 10~~herewith.~~7 and 10.8.~~

~~Subordinated Convertible Promissory~~+ ~~Notes~~Indicates ~~Issued~~management tocontract ~~our~~or ~~CFO,~~compensatory ~~Executive Chairman and CEO~~plan.

The foregoing summaries of certain terms of the Notes are qualified in their entirety by the terms of the Notes, a copy of which is attached hereto to this Quarterly Report on Form 10Q as Exhibit 10.9.SIGNATURES

35Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

~~Item~~Dated: 6.November 19, ~~Exhibits~~2025

Exhibit Number		Exhibit Description
3.1*		Articles of Incorporation, as amended.
3.2		Bylaws, as amended (incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10, filed with the SEC on February 12, 2025).
10.1		Form of Amended and Restated Membership Interest Purchase Agreement dated July 14, 2025 among the Company, BSG Holdings, Inc. and JBAH Holdings, Inc. for the acquisition of Ballengee Group, LLC (incorporated by reference to Exhibit 10.01 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.2		Form of Participating Note dated July 14, 2025 issued in connection with the Ballengee Group, LLC acquisition (incorporated by reference to Exhibit 10.02 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.3		Form of Lock-Up Agreement entered into in connection with the Ballengee Group, LLC acquisition (incorporated by reference to Exhibit 10.03 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.4		Form of Promissory Note entered into by and between Campbell Trust (Jeff Campbell) and the Company dated September 25, 2024 (incorporated by reference to Exhibit 10.05 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025).
10.5		Form of Promissory Note entered into by and between Campbell Trust (Jeff Campbell) and Ballengee Group, LLC dated June 2, 2025 (incorporated by reference to Exhibit 10.06 of the Registrant’s Form 8-K filed with the SEC on July 18, 2025)
10.6		Form of Consulting Agreement with Jeff Campbell to serve as Executive Chairman, dated June 30, 2025 (incorporated by reference to Exhibit 10.2 of the Registrant’s Form 10-K, filed with the SEC on July 3, 2025).
10.7*+		Form of Employment Agreement with Marilu Brassington dated August 14, 2025
10.8*+		Form of Option issued to Marilu Brassington
10.9*+		Form of Subordinated Convertible Promissory Note issued to Marilu Brassington, Jeff Campbell, and Adam Nicosia
10.10*		Form of Convertible Promissory Note issued to investors.
31.1 & 31.2*		Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2003.
32.1 & 32.2**		Certifications of CEO And CFO Pursuant To Section 906 Of The Sarbanes-Oxley Act

Adapti, Inc.

*By: ~~Filed~~/s/ ~~herewith~~Adam Nicosia Adam Nicosia Title: Chief Executive Officer

** Furnished herewith.48

+ Indicates management contract or compensatory plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 14, 2025

Adapti, Inc.

By: /s/ Adam Nicosia Adam Nicosia Title: Chief Executive Officer

Filing Compare · Adapti, Inc.